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Background and Aims: Rhinitis is a common global disorder which impacts on the quality of life of 
the sufferer and caregivers. However, infant onset rhinitis, especially its relationship with respiratory 
viruses, is still understudied. The aims of this thesis were to evaluate the epidemiology of rhinitis in 
the first 18 months of life of the Singaporean birth cohort - Growing Up in Singapore Towards 
healthy Outcomes (GUSTO) and to explore the role of respiratory viruses in the symptomatology of 
rhinitis in infancy. 
Methods: Newborns of the GUSTO birth cohorts (n=1247 recruited) were followed from birth and at 
scheduled visits at 3 weeks, 3, 6, 9, 12, 15, and 18 months of age. During these visits, subjects were 
screened for the presence of rhinitis symptoms (sneezing, runny/blocked nose) that lasted 2weeks 
using questionnaire. Subjects who were positive for rhinitis were then given additional monthly phone 
calls to obtain symptom details (duration, symptoms present, severity, and disturbances).  During each 
visits, subjects were also sampled by anterior nasal swabbing for molecular-based respiratory viruses 
detection. Skin prick testing for common food and house dust mite allergen sensitization was 
conducted at the 18th month visit. Subjects who remained positive for rhinitis during the monthly calls 
were invited for additional visits where clinical assessments and additional nasal swabbing were 
conducted. 
Results: Rhinitis was found to be present in 32.1% of 733 subjects with available data. A subgroup of 
rhinitis termed prolonged/recurrent rhinitis was identified (total symptom duration 4weeks, with 
each episode at least 2 weeks). The prevalence of prolonged/recurrent rhinitis was 18.8%. 
Prolonged/recurrent rhinitis, but not rhinitis of shorter duration, was found to be associated with 
atopic co-morbidities (eczema and wheeze), and with parental history of atopic symptoms. In 
addition, prolonged/recurrent rhinitis resulted in sleeping and feeding disturbances in 71.7% and 
57.2% of the afflicted subjects respectively. Analysis of scheduled visits nasal swab samples collected 
from 32 prolonged/recurrent rhinitis subjects and their matched controls did not reveal any 
significantly different rate of respiratory virus detection. However, nasal samples collected from 
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subjects with prolonged/recurrent rhinitis at the additional clinic visits (within a month of rhinitis 
episodes 2weeks) revealed a significantly (p=0.04) higher respiratory virus detection rate compared 
to the scheduled visit swabs. 
Conclusions: Based on duration of symptoms, this study has identified the criteria of rhinitis 
(prolonged/recurrent) in the first 18 months of life which was associated with atopic co-morbidities 
and parental history. Results from the analysis of 32 pairs of scheduled samples indicate that 
prolonged/recurrent rhinitis subjects were not more susceptible to persistent virus detection. However, 
the significantly higher respiratory virus detection within a month of rhinitis episodes suggests that 
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Chapter 1: Introduction 
Rhinitis is an inflammation of the upper nasal lining, presenting typically with 
symptoms of runny nose (rhinorrhea), nasal blockage, and/or sneezing. While not 
typically fatal, it does impose significant health, psychological, and monetary burden 
to its sufferers, and is thus considered a global health problem (1-4). Rhinitis was also 
reported to be common in school age as reported by the ISAAC (International Study 
of Allergy and Asthma in Childhood) project, an international questionnaire-based 
study on allergic disorder epidemiology (5). The ISAAC reported average global 
rates of rhinitis among 6-7 years and 13-14 years school children were 20.7% (range: 
7.4% - 43.4%) and 33.2% (range: 10.4% - 80.6%) respectively (6) In addition, there 
is a probable link between rhinitis with future wheeze and asthma development (7-9). 
Rhinitis in early childhood (infancy and preschool; 0-6 years) has not been as 
extensively studied as its allergic counterparts: asthma and eczema. This may stem 
from the concept of the atopic which describes allergic rhinitis as a manifestation of 
later childhood (7, 10). However, the result from a Singaporean cross-sectional 
questionnaire survey reported that nearly half of the Singaporean infant population 
had had rhinitis within the first 2 years of life (11). This result suggests that contrary 
to the atopic march model, rhinitis may have an early onset.  
Rhinitis in early life is easily mistaken for recurrent infectious rhinitis (back-to-back 
infections of the upper airways), which is common in childhood (1). This may be 
another reason for its trivialization and hence the knowledge gap. A Singaporean 
study (12) reported that the majority of rhinitis in infancy was non-allergic. However, 
another study from Thailand showed that a subset of non-allergic rhinitis in young 
children may evolve subsequently to allergic rhinitis (13), indicating an evolving 
phenotype with age. Thus it appears possible that the clinical manifestations of 
rhinitis may precede the development of atopy/allergen sensitization, and that further 
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research into rhinitis in early childhood is necessary to understand the beginnings of 
this disorder.  
This thesis will begin by summarizing the knowledge from recent studies on rhinitis 
in early childhood.  
1.1. Method of Review 
A Pubmed search was conducted to review our recent knowledge on early childhood 
(infancy and preschool; 0-6years) rhinitis (Figure 1.1). The search terms: "rhinitis" 
AND ‘"preschool” OR “infant” OR “infants” OR “infancy"’, filtering for English 
articles published from January 2006 until December 2014 returned a total of 1284 
hits. Excluded were papers without English texts (n=2), papers with irrelevant topics 
(did not describe or analyze rhinitis, did not analyze rhinitis as a separate entity from 
other diseases, used adults or animal models, focused on bacterial infection of the 
sinus cavity [sinusitis], or were clinical therapeutic trials) (n=509), reviews or 
responses to other articles (n=129), case series/report studies (n=8), and studies which 
did not specifically analyze rhinitis in 6 years of age or below (n=485). 
A total of 151 papers fulfilled the screening criteria; however, 6 of these were not 
accessible. Based on their abstracts, 2 discussed the role of breastfeeding which was 
also covered by other included articles, one paper discussed on economic burden, 
whereas rhinitis was not the main outcome of the remaining 3 articles. Thus, their 
exclusions were not deemed to impact this review significantly. 
This review section summarizes the current knowledge on the epidemiology of early 
childhood rhinitis; in particular, on the prevalence rates, phenotypes, associated co-




















Figure 1.1. Flowchart of literature review process for the current knowledge on early 
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1.2. Classification of Early Childhood (Infancy and Preschool Age; 0-6years) Rhinitis 
According to the ARIA (Allergic Rhinitis and its Impact on Asthma) guideline, 
rhinitis is classified as allergic or non-allergic based on the triggering factors (1). 
Several other guidelines such as the British Society for Allergy and Clinical 
Immunology (BSACI) guideline (14), the recently published Japanese guideline (15), 
and European Academy of Allergy and Clinical Immunology (EAACI) Taskforce 
position paper guideline for paediatric rhinitis (2) further separate non-allergic rhinitis 
to infectious and non-infectious rhinitis. This classification may be more suited for 
rhinitis in early childhood, due to the prominent role of infection as the cause of 
rhinitis within this age group (1). Based on this, figure 1.2 depicts an adaptation of 
rhinitis classification which may be best suited for rhinitis in early childhood (infant 








Figure 1.2. Classification of etiologies of rhinitis in early childhood (infancy and 
preschool age; 0-6years). Non-allergic rhinitis with eosinophilic 
syndrome, occupational, drug-induced and hormonal removed from 













1.3. Prevalence of Rhinitis in Early Childhood (Infancy and Preschool Age; 0-6years) 
The reported prevalence rates of early childhood rhinitis across cross-sectional 
studies are summarized in Table 1.1 (Page 7). Studies are grouped by definition used 
(ISAAC definition, doctor diagnosed, or other definitions) and further sorted by 
reported rates. As depicted in Figure 1.3, most of the studies were conducted in the 
Asia-Pacific region and in Europe. The reported rates varied greatly across different 
studies, ranging from 1.5% up to 67%, similar to that observed among 6-7 years old 
school children in the ISAAC study (6). There seemed to be a trend of higher 
reported rates in the Asia-Pacific region as compared to the European regions, with 
the exception of Japan (rates <7% across 5 studies) and Portugal (>43% in 2 studies). 
The low rate of rhinitis in Japan compared to its neighbor South Korea (10.1% - 
40.7%) seems to be limited to rhinitis in early childhood (prior school-age) as the 
ISAAC reported that the prevalence among 6-7 years school children to be 33.1% in 
Japan, compared to 25.0% and 27.8% from 2 centers in South Korea. 
While there may be real geographical differences in prevalence rates across different 
study locations, the differences in the definitions of rhinitis used across these studies 
may have also contributed to the wide variation in reported prevalence rates. The lack 
of uniform definition of rhinitis hinders the comparison of prevalence rates across 
studies. Most studies adapted or modified the validated questionnaire of the 
International Study of Allergy and Asthma in Childhood (ISAAC) (5) which defined 
rhinitis as symptoms of sneeze, runny, or blocked nose when the child had no 
cold/flu. Some studies, on the other hand, opted to assess for rhinitis by physician 
diagnosis or even mere parental report of rhinitis.   
Studies assessing physician diagnosed symptoms tended to report lower prevalence 
rates. This is evident in 4 studies employing both symptom-based and diagnosis-
based definitions (17-20) which showed that the latter definition resulted in lower 
6 

reported rates within each of the studies. Thus, the true prevalence may be 
underestimated by studies assessing for physician diagnosis instead of assessing for 
symptoms of rhinitis. This may signify the under-diagnosis of rhinitis symptoms by 
physicians, which may stem from its trivialization.  
A study in Brazil (21) and another in Singapore (11) assessed allergic rhinitis 
symptoms within the first 2 years of life using the ISAAC definition and reported 
prevalence rates of more than 42%. Results from both studies suggest that rhinitis in 
the first 2 years is more common than the general impression, and thus deserves more 
attention.  
Table 1.2 (Page 12) summarizes the prevalence rates of early childhood rhinitis 
among prospective cohort studies. Unlike cross-sectional studies, prospective birth 
cohort studies on early childhood rhinitis in the Asia Pacific region are lacking. 
Studies in populations from Europe and the United States showed similarly wide 
variability as was observed from cross-sectional population studies The reported rates 
of rhinitis in the first year of life was shown to reach 49% as reported in two studies 
from the US: the CCCEH (Columbia Center for Children’s Environmental Health) 
cohort (22) and the CCAAPS (Cincinnati Childhood Allergen and Air Pollution 
Study) cohort (23), further substantiating the relatively high prevalence of rhinitis in 
infancy. A study in Sweden, however, reported a rate of 0% and 0.8% in the first 6 
and 12 months of their subjects respectively (24). The low rate reported in the 
Swedish cohort may be in part due to their definition of rhinitis requiring at least two 





Table 1.1. Cross sectional studies on rhinitis prevalence in early childhood, sorted by definition: ISAAC (blue rows), doctor-diagnosed (purple 
rows), and other definitions (red rows). Each definition groups further sorted by prevalence in descending order. 
Author; Year Country Age group Rhinitis definition Prevalence 
Kim et al; 2013 (93) S. Korea 3 - 6 years Rhinitis: ISAAC definition, in the past 12 
months 
Atopic subjects: 67 of 131 (51.1%) 
Non-atopic subjects: 149 of 403 (37%) 
Chong Neto et al; 2014 
(21) 
Brazil 12 - 15 months ISAAC  Allergic rhinitis: 484 of 1003 (48.3%) 
Kim et al; 2013 (17) Korea 3 - 6 years ISAAC Ever rhinitis: 272 of 615 (44.2%) 
 
Rhinitis in past 12 months: 250 of 615 
(40.7%) 
 
Ever diagnosed rhinitis: 213 of 615 (34.5%) 
Morais-Almeida et al; 
2013 (18) 
Portugal 3 - 5 years ISAAC Rhinitis in past 12 months: 2179 of 5018 
(43.4%) 
 
Physician diagnosed rhinitis: 588 of 5007 
(11.7%) 
Tan et al; 2005 (11) Singapore 2 years ISAAC Rhinitis: 42.7% of 1026 
 
Rhinoconjunctivitis: 8.4% of 1026 
Dennis et al; 2012 (94) Colombia 1 - 4 years Allergic rhinitis: ISAAC definition Allergic rhinitis: 145 of 466 (36.4%) 
Siriaksorn et al; 2011 
(95) 
Thailand 3 – 6 years ISAAC Rhinitis: 28% of 2301 
Kong et al; 2009 (96) China 3 – 6 years ISAAC Rhinitis: 27.1% of 1211 
 






Tham et al; 2007 (98) 
Zuraimi et al; 2008  (99) 
Zuraimi et al; 2011 (100) 
Singapore 1.5 – 6 years ISAAC rhinitis past 12 months Rhinitis: 1214/4759 (25.6%) 
Rhinoconjunctivitis: 367/4759 (7.8%) 
 
Tai et al; 2009 (101, 102) Australia 4 – 5 years Allergic rhinitis: ISAAC 20.8% of 1509 
Hsu et al; 2012 (19) Taiwan 0 -5 years ISAAC definition in the past 12 months ISAAC AR (with doctor diagnosis): 
<3years old: 44.2% (12.6%) 
3years old: 49.5% (16.6%) 
4years old: 49.1% (19.6%) 
5years old: 51.7% (20.3%) 
Peroni et al; 2008 (103) Italia 3 - 5 years ISAAC Rhinitis past 12 months: 254 of 1420 (17.9%) 
Peroni et al; 2009 (20) Italy 3 – 5 years ISAAC In the past 12 months: 236 of 1402 (16.8%) 
Doctor diagnosed: 56 of 1402 (4.0%) 
Hammer-Helmich et al ; 
2014 (104) 
Denmark 3 and 6 years Current hay fever: ISAAC symptoms in past 12 
months 
Current hay fever: 
7.5% at 6 years  
Bröms et al; 2013 (105) Sweden 1 - 6 years Ever had hay fever and currently has ISAAC 
symptoms  
 
Prevalence of current ISAAC rhinitis: 
234 of 4886 children (4.8%) 
Prevalence of diagnosed rhinitis with current 
ISAAC symptoms: 
103/4886 (2.1%) 
Cho et al; 2014 (106) Korea 2 - 6 years Doctor diagnosed allergic rhinitis Ever: 348 of 1002 (34.7%) 
In the past 12 months: 215 of 1002 (21.5%) 
Zhang et al; 2013 (107) China 3 - 5 years Clinical AR: confirmed by medical history, 
clinical examination and SPT  
Epidemiological AR: 
At least 2 of itchy nose, sneezing, runny or 
blocked nose for at least 1 hour on most days 
during the past 1 year 
Clinical AR: 14.9% 
 
Epidemiological AR: 48% 
 






Hattaka et al; 2009 (108) Finland 1 - 6 years Physician diagnosed allergic rhinitis 1-3 years: 4.6% 
4-6 years: 9.3% 
Overall: 7.6% 
Schäfer et al; 2009 (109) Germany 5 – 6 years Doctor diagnosis of allergic rhinitis (hay fever) 
since birth 
5.0% of 606  
Dong et al; 2008 (110) China 1 – 6 years Doctor diagnosis of allergic rhinitis 136 of 3,945 (3.5%) 
Hayashida; 2010 (111) Japan 0 – 6 years Doctor diagnosed allergic rhinitis 25 of 913 (2.8%) 
Dong et al; 2011 (112) China 2 – 6 years Doctor diagnosed allergic rhinitis 243 of 8819 (2.8%) 




Doctor diagnosed allergic rhinitis 10 of 400 (2.5%) 
Rodrigues et al; 2013 
(114) 
Portugal 4.2 -73.6 
months 
Rhinitis symptoms: nasal discharge, blockage, or 
sneezing 
384 of 573 (67.0%) 
Vazquez-Nava; 2006 
(115, 116) 
Mexico 4 – 5 years Allergic rhinitis: snore, itchy/stuffy nose without 
cold/flu 
334 of 1160 (28.8%) 
Virkulla et al; 2011 (117) Finland 3 - 6 years Yes to: "Does your child have allergic rhinitis" 
 
Perennial rhinitis: Nasal blockage or rhinorrhea 
occurring not only seasonally 
Allergic rhinitis: 16 of 95 (17%) 
Perennial rhinitis: 22 of 95 (23%) 
Baek et al; 2013 (118) S. Korea 0 - 6 years Yes to "has your child ever had allergic rhinitis" 204 of 1136 (18.0%) 
 
Liukkonen et al; 2008 
(119) 
Finland 1 – 6 years Yes to the question: “Does your child have 
allergic rhinitis?” 
236 of 1471 (16.0%) 
Sousa et al; 2012 (120) Brazil 0 - 4 years Not specified Rhinitis: 316 of 1185 (12.8%) 
Yuksel et al; 2008 (121) Turkey 0 - 6 years Allergic rhinitis: Sneeze/blocked nose without 
cold past 12 months 
0 – 3 years: 13 of 106 (12.3%) 
3 – 6 years: 12 of 140 (8.6%) 





Paunio et al; 2006 (123) Finland 6 years Not specified 1647 of 23553 (7%) 
Ryozawa et al; 2007 
(124) 
Japan 4 years Allergic rhinitis: recurrent nasal discharge or 
blockage with attacks of sneezing 
28 of 410 (6.8%) 
Fukiwake et al; 2008 
(125) 
Japan 6 years Parent reported rhinitis 3.3% of 460 
Osawa et al; 2012 (126) Japan 18 months JG-AR guideline definition:  
rhinorrhea, antigen sensitization, and nasal 
eosinophils positive 











Tan, 2006 (4-6years):25.3%£ 
Zuraimi 2008 (1.5-6years): 25.6%£ 
Tan, 2005 (2years): 42.7%£ 
 
Japan: 
Osawa, 2012 (18months): 1.5%¥ 
Shinohara, 2007 (1.8-18.8months):2.5%¶ 
Hayashida, 2010 (0-6years): 2.8%¶ 
Fukiwake, 2008 (0-6 years): 3.3%¥ 
Ryozawara, 2007 (4years): 6.8% ¥ 

Italy: 
Peroni 2009 (3-5years): 
16.8%£, 4%¶ 
Peroni 2008 (3-5 years):17.9%£ 
Finland: 
Paunio 2006 (6 years): 7%¥ 
Hattaka 2009 (1-3years): 4.6%; (4-6years): 9.3%¶ 
Liukkonen 2008 (1-6years): 16%¥ 
Virkulla, 2009 (3-6years): 17%¥ 
Turkey: 
Yuksel, 2008  
(0-3years): 12.3%; (4-6 years): 8.6¥ 
 
Mexico: 
Vazquez-Nava, 2006 (4-5y): 28.8%¥ 
 
China: 
Dong, 2011 (2-6years): 2.8%¶ 
Dong, 2008 (1-6years): 3.5%¶ 
Kong, 2009 (3-6years): 27.1%£ 
Zhang 2013 (3-5years): 14.9%¶, 48%¥ 
 
Germany: 
Bröms 2013 (1-6 years): 4.8%£, 2.1%¶ 
Schäfer 2009 (5-6years): 5%¶ 
Australia: 
Tai, 2009 (4-5years):20.8%£ 
Brazil: 
Sousa, 2012 (0-4years): 12.8%¥ 
Chong Neto, 2014  (12-15months):48.3%£ 
 
Thailand: 
Siriaksorn 2011 (3-6years) 28%£ 
 
Colombia: 
Dennis, 2012 (1-4years):36.4%£ 
 
Korea: 
Hwang 2007 (4-6years): 10.1%¥ 
Baek 2013 (0-6 years): 18.0%¥ 
Cho 2014 (2-6years): 21.5%¶ 
Kim 2013 (3-6years): 40.4%£ 
Kim 2013 (3-6years):40.7%£, 34.5%¶ 
Portugal: 
Morais-Almeida 2013 (3-5years: 43.4%£, 11.7¶ 
Rodrigues: (4.2-73.5 months): 67.0%¥ 
 
Denmark: 
Hammer-Helmich 2013 (6years):7.5%£ 
USA: 
Garg, 2014 (0-5years): 11.6%¶ 
 
Figure 1.3. Prevalence rates of early childhood rhinitis from cross-sectional studies conducted since 2006 across the globe. Prevalence rates of each 
studies were colour coded: blue (10%), purple (10.1% - 30%), red (>30%). £ISAAC definition, ¶physician diagnosed, ¥other definitions. 






Table 1.2. Prospective birth cohort studies on early childhood rhinitis sorted by region. 
Author; Year Country (Cohort name) Rhinitis definition 
Age of 
analysis Prevalence 
Perzanowski et al; 
2006 (22) 
USA (CCCEH birth cohort) Allergic rhinitis: Runny nose, 
sneezing, or itchy eyes without 
cold 
3 years 0-12months: 49% of 265 
13-24months: 34% of 203 
25-36months: 33% of 163 
Perzanowski et al; 
2008 (51) 
USA (CCCEH birth cohort) Rhinitis: Runny nose, sneezing or 
itchy eyes without cold 
5 years 2 years:32.4% of 321 
3 years: 28.8% of 333 
5 years: 30% of 233 
Donohue et al; 2008 
(50) 
USA (CCCEH birth cohort) Rhinitis: Sneezing or runny nose, 
with itchy/runny eyes not from 
cold 
3 years 241 of 404 (60%) 
Lovasi et al; 2013 
(61) 
USA (CCCEH birth cohort) Rhinitis: ISAAC definition for 
hayfever 
5 years 15 of 492 (3%) 
Biagini et al; 2006 
(23) 
USA (CCAAPS cohort) Rhinitis: ISAAC in past month. 
Allergic if SPT positive 
1 year Rhinitis: 49% 
Allergic rhinitis: 9% 
Codispoti et al; 
2010 (45) 
USA (CCAAPS cohort) Rhinitis: ISAAC in past 12 
months. Allergic if SPT positive 
3 year Rhinitis: 35% of 606  
Allergic rhinitis: 19% of 606 
Rothers et al; 2011 
(76) 
USA (IIS birth cohort) Doctor  diagnosed allergic rhinitis 5 years 38 of 192 (19.8%) 
Marinho et al; 2007 
(41, 46) 
UK (MAAS cohort) Rhinitis: 
Sneezing, runny/blocked nose 
without cold or chest infection 
5 years Rhinitis (lifetime and past 
12months): 
28.2% and 26.1% of 815 
subjects respectively 
Rhinoconjunctivitis in past 





Doctor diagnosed rhinitis: 
5.3% 
Semic-Jusufagic et 
al; 2010 (127) 
UK (MAAS cohort) Rhinitis: 
Runny/blocked nose without cold 
or chest infection 
5 years Ever rhinitis at 5 years: 
154/509 (30.3%) 
Current rhinitis at 5 years: 
144/509 (28.3%) 
Roduit et al; 2014 
(26) 
Austria, Finland, France, 
Germany, and Switzerland 
(PASTURE birth cohort) 
Allergic rhinitis: Symptoms (itchy, 
runny, or blocked nose without a 
cold and associated with red itchy 
eyes) or doctor diagnosed AR 
6 years Ever had AR till 6 years: 
64 of 848 (7.6%) 
Genunuit et al; 
2014 (27) 
Germany Allergic rhinitis: ISAAC 1-4 years Ever had AR till 4 years: 
Parent report: 109/770 
(14.2%) 
Physician diagnosed: 48/770 
(6.2%) 




Doctor diagnosis of allergic 
rhinitis 
6 years 102 of 1253 (8.1%) past 12 
months 
Illi et al; 2014 (25) Germany 
(PAULA birth cohort) 
Allergic rhinitis: ISAAC 4 – 5 years Current AR: 68 of 494 
(13.8%) 
Morgenstern et al; 
2008 (62) 
Germany 
(GINI and LISA cohort) 
Hay fever: ISAAC rhinitis 4 and 6 years Hay fever symptoms: 
4 years: 278 / 2,696 (10.3%) 
6 years: 452 / 2,852 (15.8%) 
Diagnosed hay fever: 
4 years: 72/2776 (2.6%) 
6 years:162/2807 (5.8%) 




Allergic rhinitis: runny nose with 
teary eyes 
6 years Current rhinitis at: 
1.5 years: 22/816 (2.7%) 
2 years: 19/794 (2.4%) 









Allergic rhinitis: ISAAC 6 years Symptoms: 284 of 2053 
(13.8%) 
Doctor diagnosed: 83 of 
2039 (4.1%) 




Doctor diagnosis of allergic 
rhinitis 
6 years 58 of 1690 (3.4%) 
Berthelsen et al; 
2014 (129) 
Norway (Norwegian Mother and 
Child Cohort study) 
Rhinoconjunctivits: ‘‘allergy 
affecting eyes or nose, eg, hay 
fever’’  
3 years Between 18 – 36 months: 
3.6% of 40614 
Saunes et al; 2012 
(130) 
Norway 
 (PACT cohort) 
Rhino-conjunctivitis: 
Hay fever, sneezing or itchy-
watery eyes 
2 and 6 years 2 years: 279 of 4746 (5.9%) 
6 years: 255 of 2178 
(11.7%) 
Baiz et al; 2014 
(75) 
French (EDEN birth cohort) Rhinitis:  
ISAAC symptoms accompanied 
by itching of the eye and tearing 
past 12 month 
4 – 5 years 7.5% of 239 
Herr et al; 2011 (39, 
43) 
French (PARIS cohort) Rhinitis: ISAAC definition 
Allergic if allergen sensitized 
18 months Rhinitis in past 12 months: 
169 of 1850 (9.1%). 
Allergic: 70 of 1850 (5.4%) 
Rancière et al; 2013 
(40) 











ISAAC symptoms accompanied 
by itching of the eye and tearing 
past 12 month 









Allergic rhinitis: Same as above 5 years 185 of 1288 (14.4%) 
Nwaru et al; 
2011(71)  




Rhinitis: Same as above 5 years Rhinitis at 5 years: 442 of 
3112 (14%) 
Nwaru et al; 2012 
(32) 




Allergic rhinitis: Same as above 5 years Cumulative AR at 5 years:  
359 of 2441 (15%) 
Kurukulaaratchy et 
al; 2011 (131) 
UK (Isle of Wight cohort) Rhinitis: ISAAC 1-2, 4 years Rhinitis prevalence: 
At 1-2years: 217 of 1377 
(15.8%) 
At 4 years: 65 of 1214 
(5.4%); 33 (3.4% of total) 
atopic rhinitis 
Chawes et al; 2011 
(132) 
Denmark (COPSAC birth 
cohort) 
Rhinitis: ISAAC 
Allergic if diagnosed by study 
doctors based on sensitization 
6 years Allergic rhinitis: 24 of 369 
(9.3%) 
Folsgaard et al; 
2012 (133) 
Denmark (COPSAC birth 
cohort) 
Same as above 6 years Allergic rhinitis:13% 
Kreiner-Møller et 
al; 2012 (134) 
Denmark (COPSAC birth 
cohort) 
Rhinitis: same as above 
Allergic if both sensitized and 
exposed with relevant inhalant 
allergens 
6 years Allergic rhinitis: 24 of 240 
(10%) 
Non-allergic rhinitis: 58 of 
240 (24%) 
Ghunaim et al; 
2006 (135) 
Sweden (BAMSE birth cohort) Rhinitis: ISAAC definition 4 years 280 of 2551 (11%) 
Mai et al; 2007 
(136) 
Sweden (BAMSE birth cohort) Rhinitis: Runny/blocked nose 
without cold in past 12m 





Westman et al; 
2012 (42) 
Sweden (BAMSE birth cohort) Rhinitis: ISAAC definition or 
reported upper-airway symptoms 
after exposure to pollen or furred 
animal 
Allergic rhinitis if inhalant 
sensitized 
4 years Allergic rhinitis: 108 of 
2024 (5.4%) 
Non-allergic: 161 of 2024 
(8.1%) 
 
Ballardini et al; 
2012 (137) 
 
Sweden (BAMSE birth cohort) Rhinitis: 
1 & 2 years: Prolonged rhinitis 
symptoms of 2 months in the 
past 12 months 
4 years: prolonged rhinitis without 
a common cold in the past 12 
months 
1, 2, and 4 
years 
Rhinitis prevalence: 
1 year: 103/2916 (3.5%)  
2 years: 112/2916 (3.8%) 
4 years: 314/2916 (10.8%) 
Magnusson et al; 
2013 (72) 
Sweden (BAMSE birth cohort) Rhinitis: 
1 & 2 years: Prolonged rhinitis 
symptoms of 2 months in the 
past 12 months 
4 years: prolonged rhinitis without 
a common cold in the past 12 
months 
1, 2, and 4 
years 
Rhinitis prevalence: 
1 year: 116/3285 (3.5%)  
2 years: 128/3285 (3.9%) 
4 years: 353/3285 (10.7%) 
Back et al; 2009 
(30) 
Sweden Allergic rhinitis: ISAAC definition 6 years 18 of 123 (14.6%)  
Alm et al; 2011 (29) Sweden Current AR: 
Sneezing, runny/blocked nose or 
red&itching eyes after contact 
with furry animals, leafing or 
grass in the past 12 months 
4.5 years Current AR: 246 of 4465 
(5.5%) 
Doctor diagnosed: 75 of 
4465 (1.7%) 
Soderstrom et al; 
2011 (24) 
Sweden Rhinoconjunctivitis: 
"Symptoms of rhinitis and/or 
6, 12, 18, 24 
months and 5 
Rhinitis: 





conjunctivitis appearing at least 
twice after exposure to a particular 
allergen and unrelated to 
infection." 
years 12 months: 2 of 265 (0.8%) 
24 months: 7 of 261 (2.7%) 
60 months: 38 of 240 
(15.8%) 
Eifan et al; 2009 
(138) 
Turkey Rhinitis: ISAAC definition 2 and 5 years 2 years: 13% in the past 12 
months 
5 years: 26.1% in the past 12 
months 
Stoltz et al; 2013 
(44) 
Australia (COAST birth cohort) Rhinitis: “Routinely or seasonally 
having frequent sneezes and/or 
itchy/runny nose” 
6 years 116 of 252 (46%) 
Thomson et al; 
2010 (35) 
Australia (MACS cohort) Allergic rhinitis: Runny/blocked 
nose requiring antihistamine 
and/or nasal steroid in past 12 
months 
6 years AR at 6 years: 16% of 486 
Marshall et al; 2007 
(139) 
Australia (CAPS cohort) Rhinitis: Itchy nose, sneeze, 
runny/blocked nose lasted 1 or 
more week 
5 years 219 of 516 (42%) 
Gillespie et al; 2006 
(67) 
New Zealand Rhinitis: runny/blocked nose 
without flu 







Figure 1.4. Prevalence rates of early childhood rhinitis from prospective cohort studies conducted since 2006 across the globe. ¶Prevalence in the last 12 
months (current symptoms), †Prevalence since birth (symptoms ever), £Symptom with allergen sensitization. ¥Physician diagnosis requirement 
World Map Image obtained from:http://upload.wikimedia.org/wikipedia/commons/1/14/BlankMap-World-large.png 
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1.4. Phenotypes of Early Childhood Rhinitis 
Past studies on early childhood rhinitis have frequently used the term "allergic 
rhinitis" to refer to rhinitis symptoms even in the absence of testing for allergen 
sensitization (22, 25-36). However, early childhood rhinitis is likely to be 
heterogenous and consists of several phenotypes similar to that for wheezing and 
asthma in this age group (37, 38). The PARIS (Pollution and Asthma Risk: an Infant 
Study) birth cohort analyzed rhinitis (by ISAAC definition) subsets based on the 
presence of atopic markers defined as elevated eosinophil, high serum total IgE level, 
or presence of allergen sensitization (39). Their results showed that allergic rhinitis, 
but not non-allergic rhinitis in the first 18 months of life was associated with parental 
history of allergic rhinitis, low socioeconomic status, male gender and the presence of 
cockroaches in the environment. In a separate publication, the authors identified two 
phenotypical patterns of rhinitis for age one to four years: a transient rhinitis 
phenotype remitted after 1st year of life, and a cough/rhinitis phenotype which 
persisted up till the 4th year of life (40). They also reported that only the 
cough/rhinitis phenotype was associated with atopic co-morbidities, risk factors, and 
sensitization markers.   
To date, the PARIS birth cohort is the only cohort with descriptions of phenotypes of 
rhinitis with onset in infancy. To fill the gaps in our knowledge of early onset rhinitis, 
this thesis would focus on closer evaluation of rhinitis with onset in the first 18 
months of life and describe its association with atopic co-morbidities and putative 
risk factors. 
1.5. Relationship with Other Atopic Conditions and Allergen Sensitization. 
Eczema, wheeze, and rhinitis constitute the atopic triad. The concomitant presence of 
rhinitis with eczema and/or wheezing in the same individual is well described in early 
childhood (24, 29, 40-42). The PARIS cohort on the other hand, did not find 
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significant co-occurrence of rhinitis symptoms (ISAAC definition) in the first 18 
months with eczema or wheezing (43), which the authors attributed to the young age 
of their subjects in comparison with the other studies (at least 4 years of age). The 
association between early childhood rhinitis and allergen sensitization has also often 
been reported by numerous studies (24, 29, 41, 43-51). In addition, this relation may 
also have a dose-response relationship, i.e. a higher degree of sensitization (IgE level 
and skin prick test wheal diameter) corresponds to a higher risk for development of 
preschool rhinitis as shown by Marinho et al. (46). Results from these studies suggest 
a close relationship between early childhood rhinitis with other atopic co-morbidities, 
and also with atopic sensitization. 
1.6. Risk factors for Early Childhood Rhinitis 
1.6.1. Genetics and Heritability 
Several studies had attempted to investigate the role of genetic variants in early 
childhood rhinitis susceptibility (52-56).  
However, the contribution of genetic factors in the development of early childhood 
rhinitis had been mostly shown by its heritability. Indeed, parental histories of atopic 
symptoms are amongst the most consistently reported risk factors of early childhood 
rhinitis (25, 29, 34, 39-41, 43, 57). This heritability was further reinforced by a twin 
cohort study which observed that the concordance of preschool rhinitis was greater 
among monozygotic twins as compared to dizygotic twins (58).  
1.6.2. Environmental Exposures  
The rising prevalence of allergic diseases across the globe (59) suggests that affluent 





1.6.2.1. Environmental Pollutants  
As rhinitis is a disease of the upper airways, its association with airborne irritants 
(such as tobacco smoke) and pollutants is of particular interest.  
Studies had generally reported that tobacco exposure during pregnancy or after birth 
did not increase the risk of early childhood rhinitis (29, 34, 41, 43, 45). In contrast, 
the CCAAPS cohort reported that families who smoked a total of 20 cigarettes/day 
were a risk for rhinitis (ISAAC definition) at 1 year of age (23). However, a follow-
up of the cohort reported no association with allergic rhinitis (symptoms with 
sensitization) at 3 years (45). Tobacco exposure was later reported to be associated 
with the transient rhinitis phenotype (symptoms fell after 1st year of life) but not with 
the more persistent cough/rhinitis phenotype characterized by the PARIS cohort (40). 
This might suggest that tobacco smoke is associated with specific subsets of rhinitis, 
which may explain the association observed in the first year of CCAAPS cohort 
subjects. The ABIS (60) cohort also reported that tobacco exposure increased the risk 
of rhinitis at 3rd year of life. Unfortunately, the definition of rhinitis was not specified 
in this publication. Further studies are needed to investigate the role of both pre- and 
postnatal tobacco exposure.  
Most reports have not shown any significant association between traffic pollution and 
preschool rhinitis. The American CCAAPS cohort (45) reported an absence of 
association between traffic carbon exposure and rhinitis at 3 years. Another American 
cohort, the CCCEH cohort, showed no association between tree canopy coverage 
around the subjects’ home (suggested to reduce traffic related particulate matter) with 
rhinitis at 5 years (61). Using distance to main road as proxy for pollution, the result 
from combined GINI (German Infant Nutritional Intervention) and LISA (Lifestyle 
Related Factors on the Immune System and the Development of Allergies in 
Childhood) cohorts (62) showed significant association with rhinitis symptoms at 4 
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and at 6 years. However, this was observed only when comparing subjects living 
closest to the road compared to those living furthest away. To date, there have not 
been any reports from birth cohort studies on traffic pollution association with infant 
onset rhinitis. 
1.6.2.2. Inhalant Allergens 
Similar to outdoor airborne environmental factors, the role of indoor factors such as 
inhalant allergens from house dust is also of interest for research.  
Investigators of the PAULA (Perinatal Asthma and environment Long-term Allergy 
Study) (25) cohort measured dust mite allergen (Der p 1 and Der f 1) levels from dust 
samples collected from mattress and living room floor at 3 months of age. While 
higher dust allergen levels were a risk for development of dust mite sensitization, it 
was not found to be associated with current rhinitis symptoms (ISAAC definition) at 
4-5 years old. Investigators of the MAAS (Manchester Asthma and Allergy Study) 
cohort measured Der p 1 allergens found within dust samples (collected at birth, 3, 
and 5 years from parents’ and child’s bed, child’s bedroom floor, lounge room floor) 
and related these levels to current rhinoconjunctivitis at 5 years (41). The total dust 
allergen level was reported to have inverse association with rhinoconjunctivitis in 
non-sensitized subjects in the univariate analysis. However, the association with dust 
allergen levels was lost after statistical adjustment using multivariate analysis.  
Animal origin inhalant allergen levels were measured by the PAULA (cat allergen), 
MAAS (cat and dog), and CCEEH (50) (cockroach and mouse) cohorts. However, 
these studies did not find any association between levels of animal allergens and 
preschool rhinitis. 
Two randomized control trial studies: PIAMA (Prevention and Incidence of Asthma 
and Mite Allergy) (63) and the CAPS (Childhood Asthma Prevention Study) cohort 
(64) conducted house dust mite exposure intervention using a mite allergen 
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impermeable cover (and in CAPS, also with bed washing solution and mite avoidance 
advices).  A reduction in HDM allergen Der f 1 (but not Der p1) level from children’s 
mattresses at 4 years was reported in the intervention group compared to controls in 
the PIAMA cohort. However, no reduction in prevalence of rhinitis at fourth year was 
observed in the intervention group. Instead, the cohort also reported an increased risk 
for rhinitis accompanied with eye symptoms in the intervention group. The CAPS 
cohort also reported a reduction of HDM allergen Der p 1 level (measured at 4 weeks, 
3, 6, 9, 12 months of age and twice yearly thereafter till fifth year) in the intervention 
group but no reduction in rhinitis (parent reported sneeze, runny/itchy/blocked nose) 
at 5 years was observed. Results from these studies suggest that reducing house dust 
mite allergen levels may not protect against, and may even predispose to the 
development of preschool rhinitis. 
The PARSIFAL study encompassing 5 European countries (65) described the 
relationship between house dust allergen level and HDM sensitization within 5-13 
years old children. They reported the relationship to be bell-shaped, with the 
intermediate allergen level, but not low or high, to be a risk for the development of 
sensitization. As such, reduction of dust allergen exposure may not protect against 
and instead increase the risk of sensitization (66), which may then lead to subsequent 
respiratory atopic disorders.  
1.6.2.3. Dust Endotoxins  
Endotoxin is a lipopolysaccharide originating from the outer membrane of gram 
negative bacteria commonly found in dust, and is known to trigger inflammatory 
responses.  
Results from the American CCCEH (22), Finish DIPP (25), British MAAS (41), New 
Zealand (67), and Dutch PIAMA (68) prospective cohorts showed no association 
between house dust endotoxin levels and early childhood rhinitis. In contrast, results 
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from a joint study of the combined German GINI and LISA cohorts showed 
protective effects of higher endotoxin levels against preschool allergic rhinitis, albeit 
only in children with atopic parents (68). Another American cohort, the CCAAPS, 
reported a "bimodal" relationship between infancy endotoxin exposure and allergic 
rhinitis at 3 years (45). While medium level of endotoxin exposure was protective, 
both low and high level of exposure were risk factors for allergic rhinitis (symptoms 
with sensitization). However, all subjects of the CCAAPS cohort had at least 1 atopic 
parent and this relationship was not statistically significant when analyzing rhinitis 
symptoms regardless of sensitization status. Interestingly, the study also seems to 
have higher range of endotoxin level compared to the European birth cohorts. The 
mean and median endotoxin levels in the European studies fell in the "low endotoxin" 
group in CCAAPS. Thus, there may also be an effect of geographical differences on 
the association between endotoxin and early childhood rhinitis. 
While the prospective cohort studies had been conducted within urban setting, a 
cross-sectional study in rural areas of 4 European countries has previously plotted the 
prevalence of hay fever in 6-13 years old against endotoxin load from mattress (69). 
The study reported an inverse association between endotoxin load with hay fever as 
well as with allergen sensitization, suggesting that endotoxin may also elicit a 
protective effect on school-age rhinitis in the rural setting. The extended PASTURE 
birth cohort also studied the association between early childhood wheeze, asthma and 
sensitization with house dust endotoxin, as well as other indicators of microbial 
exposure: muramic acid (from gram positive bacteria) and ergosterol (from fungal 
exposure) (70). However, the investigators found that individual levels of endotoxin, 
muramic acid, or ergosterol were not associated with asthma or wheeze in the study. 
Intriguingly, the study reported a bell shaped association between the sum of the 
quantity of the three exposure markers and early childhood asthma.  
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Thus, the conflicting results of previous studies on the role of endotoxin exposure 
towards early childhood rhinitis may result from multiple confounding factors such as 
the parental history of atopy, geography and setting (urban or rural) of the study, and 
the composition of other microbial components within house dust samples. 
Furthermore, while most of the prospective cohorts sampled for endotoxin level 
within the first year of life, the MAAS, GINI, LISA and PIAMA cohorts measured 
endotoxin exposure after the 5th year. The difference in the age of subjects at the time 
of house dust sampling for measurement of endotoxin levels might also confound this 
association, as the effect of endotoxin exposure on allergy development is likely to 
depend on the age of exposure. More research is needed in order to tease out the 
interactions between these complex issues. 
1.6.2.4. Nutrition and Diet 
The influence of nutrient and feeding has been widely investigated. The Finland DIPP 
(Type 1 Diabetes Prediction and Prevention) cohort had conducted a comprehensive 
analysis of the role of pregnancy (31, 32, 71) and early life nutrition pattern (33, 34, 
36) on preschool rhinitis. They found that early introduction of fish protected against 
preschool rhinitis, an observation also reported by other studies (29, 72). 
Vitamin D plays a role in the development and regulation of the immune system. 
Lifestyle changes associated with decreased outdoor activities and sunlight exposure 
(leading to lower vitamin D metabolism) have been suspected to contribute to the rise 
of allergic diseases (73). Several studies have addressed the role of vitamin D in the 
development of preschool rhinitis. Back et al. (30) reported an absence of association 
between vitamin D intake level in infancy with rhinitis at 6 years of age. On the other 
hand, the DIPP cohort reported a protective effect of higher maternal Vitamin D 
intake from food during pregnancy against the development of rhinitis at the age of 5 
(74). Level of cord blood Vitamin D metabolite, 25(OH)D, is considered a more 
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direct indicator of the fetal vitamin D exposure (73). However, both the Etude des 
Déterminants pré et post natals du développement et de la santé de l’Enfant (EDEN) 
(75) and the Infant Immune study (IIS) (76) birth cohorts reported no significant 
association between cord blood 25(OH)D level with the development of rhinitis at 5 
years of age. The reason for this inconsistency is unclear and the protective effect of 
supplemental Vitamin D intake in preschool rhinitis is still controversial. 
Breastfeeding is strongly recommended for its numerous benefits to the newborns. 
However, its role in rhinitis development is disputed, as many studies reported no 
effect of prolonged breastfeeding on early childhood rhinitis (26, 34, 41, 43, 77). The 
CCAAPS cohort reported protective effect against rhinitis at 3 years, but only among 
African American (45). This finding suggests that the protective effect of 
breastfeeding on early childhood rhinitis might depend on ethnicity and regional 
practices and views.  
1.6.3. Hygiene Hypothesis: The Role of Microbial Exposures 
The "hygiene hypothesis", initially proposed by Strachan D., postulated that the 
increasing prevalence rates of atopic diseases over the past few decades may be due 
to decreased early childhood infection, which in turn is related to smaller household 
sizes, more affluent lifestyle and increased hygiene (78). He speculated that the 
absence of early life exposure to infections resulted in a ‘lack’ of anti-infection Th1 
response and consequently, a loss of down-regulation of the pro-inflammatory Th2 
response. Substantiating this hypothesis is a recent publication by Strachan D. on the 
Phase 3 (follow-up) ISAAC study (from 31 countries) which showed an inverse 
association between sibship size and rhinitis at 6-7 years (79). This association was 
especially so for affluent countries, which may suggest that protective effect of 
siblings is stronger in a ‘cleaner’ environment.   
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In contrast to the hygiene hypothesis, a good number of studies have reported that 
respiratory viral infections instead predisposed to preschool-age asthma. Results from 
the Childhood Origin of ASThma (COAST) (80, 81), Perth (82, 83), Copenhagen 
Studies on Asthma in Childhood (COPSAC) (81, 84), and WHeezing Illnesses Study 
LEidsche Rijn (WHISTLER) (85) cohorts had shown that early respiratory viruses 
infection (in particular with human rhinovirus (HRV)) was linked to future 
development of persistent wheeze or asthma. Due to the close relationship between 
rhinitis and wheeze, this study hypothesizes that there may be a probable association 
between respiratory virus infection and rhinitis as well. 
1.6.3.1. Role of Respiratory Virus Infection in Rhinitis  
Several studies have investigated the link between early childhood infections and 
preschool rhinitis outcomes. Thomson et al. (35) reported an absence of correlation 
between either gastroenteritis or lower respiratory tract infection in the first 2 years 
with current allergic rhinitis at 6 years of age. The LISA birth cohort (n=1690 
analyzed) reported that while concurrent middle ear infection (OME) was associated 
with allergic rhinitis at 6 years, OME at earlier age (0-2 years) was not (86). A case 
control study based on a primary care database record (87) reported that out of 30 
common infections (including upper respiratory infection), only bronchiolitis was 
significantly protective against later cases of hay fever within 5 years of age. 
Only few studies have directly investigated the link between detection of specific 
respiratory viruses on early childhood rhinitis. The Canadian Asthma Primary 
Prevention Study (CAPPS) cohort (88) reported a significant association between 
parainfluenza and enteroviral infections and rhinitis (defined as "runny nose or 
sneezing without apparent cold") in the first year of life. This study may have, 
however, inadvertently included cases of infectious rhinitis (cold/flu) as they reported 
a prevalence of rhinitis in the first year of life to be 95%. The authors used the 
28 

questionnaire definition of rhinitis ‘in the absence of cold/flu symptoms’ suggesting 
that this definition may not be useful to define rhinitis in infancy. 
A case-control study by Garcia-garcia et al. (89) investigated the effect of human 
metapneumovirus (HMPV) and respiratory syncytial virus (RSV) infections in the 
first 2 years on the development of rhinitis in 3-5 years old. There was numerically 
higher rates of allergic rhinitis in the HMPV (21.7%) and RSV infected groups 
(21.9%) compared to the uninfected control group (16.7%). However, these 
differences were not statistically significant. The study may not have been adequately 
powered due to small sample size in each group (23-32 subjects per group). As 
allergic rhinitis was not the primary endpoint of their study, the association was not 
further explored.  
To expand the review on respiratory viruses and its link with rhinitis, additional 
Pubmed search was carried out to extend the age group to older children. The 
following search terms: "respiratory virus" AND "rhinitis" AND '"preschool" OR 
"infant" OR "infants" OR "infancy" OR "child" OR "children" OR "childhood"' were 
used. Several of the presented studies reported rhinitis only as symptoms resulting 
from viral infection and no further study linking early childhood respiratory virus 
infection and rhinitis was found. Thus, one of the aims of this thesis work is to fill in 
this gap of knowledge by determining the link, if any, between respiratory viral 
infections and early onset rhinitis. 
1.6.3.2. Exposure to Peers: Potential Confounder of Virus – Disease Relationship 
The reported influence of exposure to other children either at daycare or at home 
(siblings) on early childhood rhinitis has been conflicting. Studies have mostly 
reported no association between either childcare attendance or presence of siblings 
and early childhood rhinitis (23, 25, 28, 32, 43, 77). The LISA cohort reported 
childcare entry at 12 months as a risk for allergic rhinitis at 2 years (28). However, it 
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was not a risk for allergic rhinitis at age 4. Childcare entry at 6, 18, or 36 months 
were also not a risk for allergic rhinitis at 2 or 4 years in the study. The CCAAPS (23) 
cohort reported that presence of siblings to be protective against rhinitis at age 1. 
Interestingly, in a follow-up publication (45), the cohort reported that the presence of 
siblings were only protective against allergic rhinitis (symptoms with sensitization), 
but not rhinitis in general at 3 years of age.  
The variability of protective role of siblings and childcare attendance may also arise 
from the multitude of factors associated with exposure to other children in early 
childhood which may not be constant between studies. For example, the presence of 
siblings may have altered the composition and diversity of the gut microbiota (90) 
which subsequently influenced the risk of preschool allergic diseases development 
(91). Exposure to other children either at daycare or at home (siblings) has also been 
reported to increase the chance of contracting respiratory virus infections and virus-
induced wheezing (92). In views of these findings, studies relating to the relationship 
between respiratory viruses and rhinitis in early childhood in this thesis will take the 
sibship size and daycare attendance into account.  
1.7. Conclusion of Review 
Despite varying prevalence, rhinitis in early childhood (infancy and preschool; 0-6 
years) appears to be a common problem. Studies have shown that heritable factors, 
such as parental history of atopic diseases, as well as personal presence of atopic co-
morbidities, and sensitization are associated with rhinitis in this age group. 
Environmental exposures and nutrition may also influence the development of rhinitis 
in early life, albeit with less consistent findings compared to the innate factors. It is 
likely that there are gene–environmental interactions, and that the effect of 
environmental exposures depends on the innate susceptibility for developing the 
disorders. Respiratory viruses have been suggested to lead into the development of 
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preschool age wheeze and asthma, yet its role on infancy and preschool rhinitis 
development remains a relatively unexplored area. The studies undertaken in this 
thesis are aimed to fill some of the knowledge gaps. 
1.8. Aims and Hypothesis 
This thesis will attempt to fill the gaps in our knowledge of rhinitis in early childhood 
(infant and preschool age; 0-6years).    
This study is based on these two related hypotheses: 
• That early onset rhinitis is a significant clinical problem and that there is a 
subset associated with atopic co-morbidities.  
• That respiratory viruses plays a role in the development of rhinitis in the first 
18 months. 
Thus, the specific aims of this study are: 
1. To examine the epidemiology of early onset rhinitis (allergic and non-allergic) by 
prospective follow-up of subjects of the Growing Up in Singapore Towards 
healthy Outcomes (GUSTO) birth cohort in order to: 
1.1. Determine the prevalence of rhinitis in the first 18 months of life within a 
Singaporean population cohort. 
1.2. Examine the risk factors for rhinitis in the first 18 months: both familial and 
environmental. 
1.3. Assess its association with atopic co-morbidities: eczema, wheezing, and 
IgE sensitization to house dust mite and food allergens. 
1.4. Measure the symptom severity and degree of disturbances of rhinitis on the 
subjects. 
2. To study the potential role of respiratory virus infection in the development of 
rhinitis in the first 18 months by anterior nasal swabbing at scheduled timepoints 
as well as near symptom episodes. 
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This study was designed to include frequent follow-up visits of infants from birth till 
the 18th month age to allow close examination of rhinitis in the first 18 months of 
life. It will also describe the relationship between early nasal respiratory virus 
infection and the development of rhinitis at early age (first 18 months), which is 
currently unclear. The result of this study will add into our knowledge on rhinitis in 
the first 18 months of life, and is hoped to substantiate the need for future 
development of clinical guidelines for infant rhinitis which is currently inadequate. 
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Chapter 2: Methods 
2.1. The GUSTO cohort: Introduction of the cohort  
The GUSTO birth cohort is a Singaporean prospective birth cohort whose primary 
aim is to investigate the role of prenatal and early life factors in the growth and 
development of later metabolic disorders such as type 2 diabetes and obesity (140). 
As such, the cohort is not an at-risk for allergy cohort. However, in addition to the 
main study’s aim, the cohort also consists of multi-disciplinary sub-domains 
investigating various other developmental outcomes including the development of 
allergy.  
 Pregnant mothers were recruited at their first trimester of pregnancy from 2 
Singapore hospitals: National University Hospital (NUH) and KK Women's and 
Children's Hospital (KKWCH). The exclusion criteria for the recruited mothers were 
(141): 
1. Not intending to deliver in either study hospitals 
2. Was more than 14 weeks of gestation during recruitment 
3. Not of Chinese, Indian, or Malay ethnicity 
4. Non-homogenous parental ethnicity (parents with differing ethnicity) 
5. Not intending to reside in Singapore the next 5 years 
6. Miscarriage history 
7. No intention to donate cord, cord blood, and/or placental samples 
8. Planning to terminate the pregnancy 
9. Multiple IVF pregnancies 
10. Younger than 18 years old 
11. Non-Singaporean citizen or permanent resident 




A total of 1247 expectant mothers were recruited into the GUSTO. Demographics 
and prenatal environmental exposure data were collected during prenatal visits. 
Ethnicity, maternal education, and housing type were assessed at the recruitment 
visit, and prenatal exposure to alcohol and tobacco smoke was assessed at a 
subsequent visit between 26 to 28 weeks gestation.   
A total of 1166 singleton infants (excluding 70 drop outs, 1 miscarriage, and 10 pairs 
of twins) were delivered and subsequently recruited into the allergy sub-study of 
GUSTO. During the delivery visit, mothers’ age, details of delivery (mode of delivery 
and antibiotic usage), gestational age, and birth order were recorded. Subsequently, 
subjects were followed-up quarterly by 7 scheduled visits within the first 18 months 
of life (at 3 weeks, 3, 6, 9, 12, 15, and 18 months of age) where anthropometric 
measurements and various diseases outcome measures were conducted. Post-natal 
lifestyle factors such as diet, breastfeeding, and medication use were also measured 
during each visits, while environmental factors (childcare, flooring, air-conditioning, 
exposure to: pets, traffic, and tobacco smoke) were measured at the 6 and 12 months 
visits (appendix, Page 103) 
2.2. Allergy Sub-study Procedures 
2. 2.1. Assessment of Clinical Outcomes and Data Collection 
As part of the GUSTO sub-study, the allergy sub-study conducted additional 
procedures to evaluate allergic diseases and the potential associated factors of rhinitis 
among the subjects of GUSTO. The flowchart of the additional measures conducted 
by the allergic sub-study is presented in Figure 2.1. At each of the 7 scheduled visits 
in the first 18 months of life, caretakers or guardians of the subjects were interviewed 
by questionnaire for the presence of rhinitis and other atopic conditions (eczema and 
wheezing). The use of medications for these atopic conditions was assessed along 
with the presence of the symptoms. Parental allergic history status was recorded at 3 
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weeks visit but was reassessed at the 18th months visit to ensure completeness of data. 
Childcare attendance within the first year of life was also reassessed at 36 months for 
data completion. Questions for clinical outcomes are summarized in table 2.1 and 
detailed in the appendix (Page 103). This allergy sub-study of the GUSTO has been 
approved by both study institutions’ ethical review boards (DSRB:B/2009/584 and 
CIRB:2009/1024/E). Written informed consent was obtained from parents or legal 
guardians of the subjects. 
During these scheduled visits, subjects with positive response for the rhinitis 
question: "Has your child ever had sneezing, running nose, blocked or congested 
nose, snoring or noisy breathing during sleep or when awake that has lasted for 2 or 
more weeks duration?” were identified and more closely followed through monthly 
phone calls to track symptoms progression until 3 months without symptoms. During 
these calls, additional symptom details such as symptoms duration, severity, and 
degree of disturbances were assessed (see section 2.2.6 Symptom Severity and 
Disturbance Scoring, Page 37 and appendix, Page 124).  
2.2.2. Questionnaire and Disease Definition 
Definitions used for clinical outcomes of rhinitis, eczema, and wheezing are 
summarized in Table 2.1 along with the corresponding survey questions.  
 The definition of rhinitis used in this study was modified from that of the ISAAC 
study (sneeze, runny or blocked nose when the child had no cold/flu). However, 
symptom cut-off duration (sneezing, runny/blocked nose which lasted for 2weeks) 
was used instead of excluding symptoms due to cold/flu. This duration cut-off of 2 
weeks is based from the ARIA guideline developed by the WHO (1), which stated 
that symptoms persisting for 2 or more weeks should be investigated for causes 
outside of upper respiratory infection. Substantiating this cut-off is a recent report that 




Recruitment (1st trimester pregnancy): 
n recruited = 1247 mothers 
26-28 week pregnancy visit: 
Delivery (n=1166 singletons) 
Allergy sub-study procedures: 
Scheduled visits: 3weeks, 3, 6, 9, 12, 15, & 18 months: 
1. Questionnaire for rhinitis, co-morbidities & environmental factors 
2. Nasal swabbing for respiratory viruses  
3. Skin prick test (SPT) (only at 18 months visit). 
Monthly phone call: 
1. Assess symptom details  
2. Track symptom progression 
3. Symptom & disturbances scoring 
Until 3 months into symptom remission 
 
Rhinitis positive at call 
Rhinitis positive in questionnaire 
Additional symptomatic visits: 
1. Additional nasal swabbing 
2. Symptom & disturbances scoring 
3. Physical examination 
Future yearly scheduled visits: 
Continuing symptom screening 
(yearly) and skin prick testing (at 3 
and 5 years) 
Figure 2.1. Flowchart of follow-up schedule of the GUSTO birth cohort 
subjects and procedures carried out by the allergy sub-study. 
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To further explore the possible phenotypes of rhinitis better associated with atopic 
history and co-morbidities, another subset of rhinitis was defined. Based on the 
results of the monthly calls, rhinitis lasting 4 or more weeks either in a single episode 
or in multiple episodes of at least 2 weeks was used to define prolonged/recurrent 
rhinitis.  
Eczema was defined as having diagnosed with eczema by our study physician, or by 
other physicians as indicated in the questionnaire.  
Wheezing was defined as a positive answer to the question "Has your child had 
wheezing i.e. Noisy breathing with a high-pitch, whistling sound heard from chest, 
not the mouth?" and also to the question for nebulizer and/or inhaler usage within the 
same scheduled time-point. The additional screening measure of including 




Table 2.1. Survey questions and study definitions for allergic diseases outcomes. 
Outcomes Questions Definition 
Rhinitis  "Has your child ever had sneezing, 
running nose, blocked or congested 
nose, snoring or noisy breathing 
during sleep or when awake that has 
lasted for 2 or more weeks duration?" 
Sneezing, runny/blocked nose 
which lasted for 2 or more 
weeks in duration 
Eczema  “Has your child ever been diagnosed 
with eczema?” (since the last visit) 
Physician diagnosed eczema 
Wheezing  Wheeze: 
“Has your child ever wheezed?”(since 
the last visit) 
High-pitch, whistling sound 
heard from chest, not the 
mouth associated with 
nebulizer/inhaler usage Nebulizer/inhaler: 
“Has your child been prescribed with 
nebulizer/inhaler treatment?” (since 
the last visit) 
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2.2.3. Nasal Swab Sample Collection 
Nasal swabbing for respiratory virus detection was also conducted at each scheduled 
visits to all consenting subjects. A dry flocked swab (COPAN, USA) was inserted to 
the nostril of the subjects until a resistance was felt, and then twisted and immediately 
transferred to a tube of 3 ml universal transport media (COPAN, USA), and stored at 
-80oC until analysis. Swabs collected at the scheduled visits were utilized to correlate 
respiratory virus detection and the outcome of rhinitis by comparison of rhinitis 
subjects with the healthy controls. 
The presence of any runny/blocked nose symptoms (not necessarily of 2 weeks 
duration) were noted by the research staffs at each nasal sampling visit. 
2.2.4. Skin Prick Tests 
During the 18th month visit, skin prick test (SPT) for sensitization to common food 
(whole egg, cow’s milk, and peanut) and house dust mites allergens (HDM: Blomia 
tropicalis, Dermatophagoides pteronyssinus, and Dermatophagoides farina) was 
conducted on all consenting subjects to capture the presence of early onset food and 
aeroallergen sensitization. SPT was performed on the upper backs of subjects where a 
drop of each allergen extract was applied, followed by a light prick with sterile 
lancets through the drop. Each test also included positive control (histamine) and 
negative controls (glycerinated buffer). Allergen extracts and controls were purchased 
from Greer Laboratories (Ca, USA), except for B. tropicalis which was obtained from 
our in-house laboratory. Positive allergen sensitization was based on wheal size 
reaction of at least 3x3mm more than the negative control. The test was considered 
valid if the positive control (histamine) was at least 3mm larger than negative control 




2.2.5. Additional Clinic Visits for Rhinitis Subjects 
Subjects who remained positive for rhinitis during each monthly call were invited to 
attend additional rhinitis visits. During these visits, subjects were given clinical 
assessment such as tonsillar, nasal patency, and otitis media examination. Additional 
nasal swabbing was also collected during these additional visits to describe pattern of 
respiratory viruses detected near (within a month) of rhinitis episodes. 
2.2.6. Rhinitis Symptom Scoring 
During monthly calls with ongoing rhinitis and during additional visits, rhinitis 
symptom severity was scored subjectively by caretakers with a four item Total Nasal 
Symptom Score (TNSS). The TNSS is adapted from the Food and Drug Association 
(FDA) recommended measurement for effectiveness in clinical trials of allergic 
rhinitis drugs (143). The TNSS consisted of blocked nose, runny nose, sneezing, and 
itchy nose symptoms, each scored from 0 (none) to 3 (severe) in the following 
manner: 
0. None 
1. Mild: Symptoms present but easily tolerated. 
2. Moderate: Symptoms are bothersome, but tolerable. 
3. Severe: Symptoms are hard to tolerate – causes marked interference with activities 
of daily living and/or sleep. 
The degree of disturbances to sleeping and feeding were scored in a similar manner. 
Sleeping disturbance was scored as follows: 
0. None 
1. Mild: Little difficulty falling asleep. Might wake up once a night every few nights. 
2. Moderate: woke up more than once a night on most nights. 
3. Severe: barely able to sleep. Awake most of the night on most nights. 
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The degree of feeding disturbance was scored as: 
0. None. 
1. Mild: Occasionally interrupted by nasal symptoms but feeds well. 
2. Moderate: Interrupted almost every feeding by nasal symptoms or feeding is 
slightly slowed down). 
3. Severe: Feeds very slowly most of the time due to interruptions or irritability. 
The total highest symptoms score in each visit intervals were summed, giving a 
maximum score of 12 per timepoint. For subjects with more than one assessments 
within a single quarterly timepoint, the highest scores for each severity and 
disturbance item were assumed for analysis.  
2.2.7. Analysis of Nasal Samples - Subject Selection 
Analysis of scheduled visits swabs were conducted by a nested case control study 
within the cohort on a subgroup of 32 case (prolonged/recurrent [4 weeks total 
duration] rhinitis) subjects and 32 healthy (no rhinitis or wheeze) control subjects. 
Analysis of the entire cohort was not conducted in view of cost considerations of 
molecular testing. However, this sample size of 32 case-control pairs was estimated 
to be sufficient for detection of 30% difference in respiratory virus detection rate 
within a single time-point. Case subjects were chosen randomly among subjects who 
had at least 4 swabs collected from the 7 scheduled visits, (n=96). For each case, 
controls were selected with matching for possible confounders (92): birth order and 
childcare attendance in the first year of life. To adjust for the timing of each swab 
collections, subjects were also matched for their month of birth. Each control subjects 
were randomly selected prioritizing subjects with the most complete swabbing. 
Every nasal samples collected during the additional visits (101 swabs from 87 
prolonged/recurrent rhinitis subjects) were also analyzed. The workflow of nasal 















2.2.8. Respiratory Virus Detection 
The molecular detection of respiratory viruses was carried out on nasal swabs 
collected at the 7 scheduled visits, as well as in additional visits (within a month of 
rhinitis episodes). This study utilized nasal swabbing in place of nasopharyngeal 
aspiration in consideration of our subjects' age and burden. Regardless, Walsh et al 
(144) had previously reported that both collection procedures yield comparable 
results.  
Total nucleic acid was extracted from samples using the QIAamp DNA Mini Kit 
(Qiagen, Germany) according to the manufacturer’s instructions. Multiplex real-time 
PCR was conducted using AB7500 fast machine (Applied Biosystems, USA) to 
detect 16 respiratory viruses across 4 multiplex panels developed by our collaborator 
Figure 2.2. Flowchart of nasal swab sample selection and analysis. 
Matched for birth 
order, birth month, 
childcare attendance. 
Most complete swab 
n= 32 control subjects 
 
At least 4 of 7 swabs 
obtained (n=96 subjects) 









Scheduled swabs  
(3 weeks, 3, 6, 9, 12, 15 & 18 months) 
Additional Visits 






Controls: No rhinitis 









and described in Tan et al (145) (Table 2.2). The multiplex panels were: panel 1 
(Human rhinovirus [HRV], Influenza A & B, Respiratory syncytial virus [RSV] 
A&B, and Human metapneumovirus [HMPV]), panel 2 (Adenovirus [AdV] and 
Bocavirus [BoV]), panel 3 (Parainfluenza virus [PIV] 1-4), and panel 4 (Coronavirus: 
OC43, NL63, HKU1, and 229E). Primers and probes used were adopted from 
multiple sources as detailed in table 3. Panel 1, 3, and 4 were conducted with 
components from SuperScript One-Step RT-PCR with Platinum Taq kit (Invitrogen, 
USA). Panel 2 was conducted using components from Platinum Quantitative PCR 
SuperMix-UDG kit (Invitrogen, USA). Each reaction was conducted in a 20µl 
reaction mix. Each sample was run in duplicates. Positive controls, purchased from 
Vircell (Spain) or gifted by TBH's lab and by Dr Lynette Oon Lin Ean from 
Singapore General Hospital Department of Pathology, were included in every run. 
Samples with amplification signal (sigmoidal curve) detected before cycle 38 were 
regarded as positive as depicted in Figure 2.3. Samples with discrepant signals 
between duplicates were repeated. 
Sub-typing of HRV was also conducted in this study. Extracted RNA from HRV 
positive samples were reverse transcribed using Roche cDNA Transcriptor Kit 
according to the manufacturer’s instructions (Roche, Swiss). Resulting cDNA 
underwent nested PCR using primers targeting the VP4-VP2 region adapted from 
Wisdom et al (146) with the Invitrogen Platinum Taq (Invitrogen, USA) according to 
the kit’s instruction. The cycling condition was: Initial denaturation at 94°C for 2 
minutes, 30 cycles of: 94oC for 30 seconds, 50oC for 1 minute, 72oC for 1 minute, and 
last extension at 72oC for 5 minutes. Resulting PCR product (around 550bp) was gel 
purified using Zymoclean™ Gel DNA Recovery Kit (Zymo Research, USA) and sent 
for sequencing to 1st Base (Singapore). The HRV subtypes were determined by 
comparing the nucleotide sequences to published subtypes deposited in Genebank 




Figure 2.3. Real-time PCR amplification curves. A) PCR amplification curve for 
Coronavirus positive control mix (purple: HKU1, Blue:229E,  
Green:OC43, Red: NL63). B) PCR amplification curves of a nasal 
swab sample with positive amplification for coronavirus OC43. A Ct 







Table 2.2. Sequence of primer and probes (reference paper), and cycling conditions of multiplex PCR for respiratory virus detection. 
Panel Respiratory Virus Primers sequence (5’      3’) (ref) Probes sequence (5’      3’) (ref) 
1 Influenza A F: AAGACCAATCCTGTCACCTCTGA (147) 
R: CCAAGCGTCTACGCTGCAGTCC  (147) 
Cy3-TTTGTGTTCACGCTCACCGTGCC-BHQ2 (148) 
Influenza B F: GAGACACAATTGCCTACCTGCTT (147) 
R: TTCTTTCCCACCGAACCAAC (147) 
Texas Red-AGAAGATGGAGAAGGCAAAGCAGAACTA 
GC-BHQ2 (147) 
Rhinovirus (HRV) F: GTGAAGAGCCSCRTGTGCT (149) 
R: GCTSCAGGGTTAAGGTTAGCC (149) 
FAM- TGAGTCCTCCGGCCCCTGAATG-BHQ1 (149) 
Metapneumovirus  
(HMPV) 
F: CATATAAGCATGCTATATTAAAAGAGTCTC (150) 
R: CCTATTTCTGCAGCATATTTGTAATCAG (150) 
Cy5- TGYAATGATGAGGGTGTCACTGCGGTTG -BHQ2 
(150) 
Respiratory Syncytial 
Virus (RSV) A  
F: AGATCAACTTCTGTCATCCAGCAA (151) 
R: TTCTGCACATCATAATTAGGAG (151) 
HEX- CACCATCCAACGGAGCACAGGAGAT-BHQ1 (151)  
RSV B F: AAGATGCAAATCATAAATTCACAGGA (151) 
R: TGATATCCAGCATCTTTAAGTA (151) 
HEX- TTTCCCTTCCTAACCTGGACATA-BHQ1 (151) 
Cycling Condition: 
UDG incubation:  50oC 2 minutes 
Initial denaturation: 95oC 2 minutes 
45 Cycles: 
Denaturation: 94oC 15 seconds 
Annealing & Elongation: 60oC 30 seconds 
Panel Respiratory Virus Primers sequence (5’      3’) (ref) Probes sequence (5’      3’) (ref) 
2 Adenovirus F: GCCACGGTGGGGTTTCTAAACTT (152) 
R: GCCCCAGTGGTCTTACATGCACATC (152) 
Cy5- TGCACCAGACCCGGGCTCAGGTACTCCGA-BHQ2 
(152) 
Bocavirus F: TAT GGC CAA GGC AAT CGT CCA AG (153) 
R: GCCGCGTGAACATGAGAAACAGA (153) 
HEX- C[C]A [C][C][A]ACWACMGMGTAG-BHQ1 (in-house 






Reverse transcription:  50oC 20 minutes 
Initial denaturation: 95oC 2 minutes 
45 Cycles: 
Denaturation: 94oC 15 seconds 
Annealing & Elongation: 60oC 1 minute 
Panel Respiratory Virus Primers sequence (5’      3’) (ref) Probes sequence (5’      3’) (ref) 
3 Parainfluenza 
(PIV) 1 
F: 5’-GGGTRCGGTGGCYTAACAACT-3’ (in-house) 
R: 5’-CATTGGTACATCTGTTTATCACACAC-3’ 
(in-house) 
UPL probe 125 (Roche Diagnostics, Germany) 
PIV 2 F: CCATTTACCTAAGTGATGGAA (154) 




PIV 3 F: GGAGCATTGTGTCATCTGTC (152) 
R: TAGTGTGTAATGCAGCTCGT (152)  
Texas Red- CGCGCTACCCAGTCATAACTTACTCAACAG 
CAACAGCGCG-BHQ2 (152) 
PIV 4 F: CCTGGAGTCCCATCAAAAGT (152) 




Reverse transcription:  50oC 30 minutes 
Initial denaturation: 95oC 5 minutes 
45 Cycles: 
Denaturation: 94oC 30 seconds 
Annealing: 55oC 30 seconds 
Elongation: 72oC 30 seconds 
Panel Respiratory Virus Primers sequence (5’      3’) (ref) Probes sequence (5’      3’) (ref) 
4 Coronavirus  
229E 
F: CATACTATCAACCCATTCAACAAG (155) 





F: CATACYCTGACGGTCACAATAATA (153) 
R: ACCTTAGCAACAGTCATATAAGC (153) 







F: TCCTACTAYTCAAGAAGCTATCC (153) 
R: AATGAACGATTATTGGGTCCAC (153) 
Cy5- TYCGCCTGGTACGATTTTGCCTCA-BHQ2 (153) 
Coronavirus  
NL63 
F: GTTCTGATAAGGCACCATATAGG (153) 




Reverse transcription:  50oC 20 minutes 
Initial denaturation: 95oC 5 minutes 
50 Cycles: 
Denaturation: 95oC 20 seconds 
Annealing & Elongation 55oC 1 minutes 
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2.2.9. Statistical Analysis 
Statistical analyses were performed on IBM SPSS Statistics version 19 (IBM, USA). 
Univariate analysis was initially conducted to individually compare putative risk 
factors, postnatal environmental exposures, and atopic co-morbidities between 
subject groups. Univariate analysis was conducted using chi-square test for bivariate 
factors, logistic regression for factors with more than 2 variables, and two sample t-
test for continuous variables. Multivariate analysis was then conducted to adjust the 
associations observed in the univariate analysis for possible covariates and 
confounding factors. Factors found to be significantly different between the 2 groups 
in the univariate comparisons were selected into multivariate analysis for adjustment. 
Multivariate analysis was conducted with logistic regression with each variables 
adjusting for each other (enter method) to assess the factors independently associated 
with rhinitis. Factors which remained to have significant association in the 
multivariate analysis were considered to be independently associated.  
Linear regression was conducted to calculate the trend of nasal symptom severity 
scores across follow-up period, and to correlate the effect of total symptom score on 
quality of life disturbances scores. 
Case-control comparison of respiratory virus detection was conducted using 
Generalized Estimating Equations (GEE).  The matching variables were included as 
the random factors. Comparison between nasal swab detection in swabs obtained 
during additional visits and during scheduled visits was conducted using logistic 
regression, adjusting for the age at the point of swabbing. A p value of < 0.05 was 




Chapter 3: Results 
3.1. Subject Demographics and Characteristics 
Of the 1247 pregnant mothers recruited into the GUSTO birth cohort, 152 dropped 
out (before and after delivery) prior to the 18th month visit. This study focused on 
singleton subjects, thus 10 pairs of twins were removed from analysis. Of the 
remaining 1085, a total of 352 subjects had missing data for rhinitis defined as either:  
A) Missing rhinitis questionnaire data from any of the 7 scheduled visit intervals and 
the absence of a positive rhinitis response in any of the other intervals; or  
B) A positive response to rhinitis but caregiver was not contactable to obtain 
symptom details of rhinitis.  
Thus, a total of 733 subjects were available for the analysis of the epidemiology of 
rhinitis in the first 18 months of life (Figure 3.1). As the rhinitis status of the subjects 
could not be confirmed when scheduled visits were missed, subjects from category 
(A) were classified as missing instead of negative for rhinitis. 
Information on the demographic background, environmental exposures, and presence 
of co-morbidities of the 733 subjects are presented in Table 3.1. The gender 
distribution was almost even. Ethnic Chinese represented more than half (64.3%) of 
the analyzed subjects, although this is lower than the general Chinese population of 
Singapore (74.2%, according to 2013 vital statistics). About one-fifth of the mothers 
and the fathers had histories of atopic symptoms. 
Skin prick tests were conducted on 651 subjects. However, 1 subject had negative 
result for positive control and was thus excluded. The overall rate of sensitization to 
any of the tested allergens was 94/647 (14.5%, 95% confidence interval (CI): 12.0% - 
17.5%). Among the 733 subjects, the prevalence rates of eczema and wheezing were 
147/667 (22.0%, 95% CI: 19.1% - 25.3%) and 77/677 (11.4%, 95% CI: 9.2% - 











Figure 3.1. Flowchart of subject selection for analysis, categorization based on 
rhinitis outcomes, and allergen sensitization rate in each outcome 
group. *Subjects with missing rhinitis data at any time point and were 
negative at all other time points were considered missing for rhinitis 
Growing Up in Singapore Towards healthy Outcomes 
(GUSTO) birth cohort (n=1247) 
Included in analysis for rhinitis in the first 18 months of life  
(n= 733) 
 
Subjects with 2 
weeks rhinitis 
confirmed by phone 
calls  
(n=235/733, 32.1%) 
*Missing rhinitis data 
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3.2. Prevalence and Clinical Characteristics of Rhinitis 
Rhinitis (sneezing, runny/blocked nose 2weeks) at any time within the first 18 
months of life was present in 235 of the 733 analyzed subjects, corresponding to a 
prevalence rate of 32.1% (95% CI: 28.8% - 35.5%). Based on the stricter definition, 
prolonged/recurrent rhinitis (symptoms 4 weeks in a single or multiple 2weeks 
episodes) was present in 138 subjects (prevalence rate = 18.8%, 95% CI: 16.2% - 
21.8%) (Figure 3.2). The median cumulative symptom duration in subjects with 
prolonged/recurrent rhinitis was 3 months (inter-quartile range: 2–4 months; range: 
1–12 months). 
Figure 3.2a depicts the cumulative prevalence of rhinitis (2weeks) and 
prolonged/recurrent rhinitis over the first 18 months. The rates increased by an 
average of 4.75% (95% CI: 4.34%–5.16%) and 2.92% (95% CI: 2.46%–3.38%) with 
each progressive time-point respectively. Figure 3.2b presents the incidence rate of 
new cases at each scheduled timepoint.  
Allergen sensitization was present in 41/197 (20.8%) rhinitis and 25/122 (20.5%) 
prolonged/recurrent rhinitis subjects (Figure 3.1), compared to 53/451 (11.8%) 
healthy subjects without rhinitis. Looking specifically at aero-allergens, house dust 
mites (HDM) sensitization was present in 30/198 (15.2%) and 19/122 (15.6%) of 
rhinitis and prolonged/recurrent rhinitis respectively, in comparison to 47/452 
(10.4%) healthy subjects. As such, majority of rhinitis and prolonged/recurrent 
rhinitis in the first 18 months of life was observed to be non-atopic in nature. 
The presence of sneezing, runny nose, blocked nose, and itchy nose (based on TNSS) 
was reported in 177 (76%), 187 (80%), 199 (85%), and 126 (54%) of the rhinitis 
subjects respectively. However, only itchy nose was significantly more common in 
rhinitis with HDM sensitization (77%) compared to those without (52%) (OR=2.98, 
95%CI: 1.21 – 7.33, p=0.014).  
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There were 118 rhinitis subjects who agreed to attend additional clinic visits which 
were carried out within a month of an episode of rhinitis. Clinical examination 
showed the presence of adenoid tonsillar hypertrophy, inflamed/enlarged tonsils, and 
middle ear infection in 9 of 109 (8.3%), 16 of 113 (14.2%), and 1 of 112 (0.9%) 
attended subjects respectively. As physical examination was not conducted on healthy 
subjects, it cannot be determined if the occurrence of these clinical features was 


























Birth 3 weeks 3 months 6 months 9 months 12 months 15 months 18 months
Rhinitis Prolonged
Figure 3.2a. Cumulative prevalence rates of rhinitis (2 weeks) and 






















3 weeks 3 months 6 months 9 months 12 months 15 months 18 months
Rhinitis Prolonged
Figure 3.2b. Incidence of newly identified rhinitis (2 weeks) and prolonged/ 
recurrent rhinitis cases across 7 timepoints in the first 18 months of life. 
*Incidence of Prolonged/Recurrent rhinitis at 3 months ecompasses new case 
from birth till 3 months
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3.3. Factors Associated with Rhinitis in the First 18 Months 
3.3.1. Univariate Comparison of Factors 
Univariate analysis was conducted to test for the association between rhinitis and its 
co-morbidities, potential risk factors (demographics and prenatal environmental 
factors), and post-natal environmental factors. The rhinitis subjects were classified 
into 3 groups and the following comparisons were made: 
Pair 1: All subjects with rhinitis versus subjects without rhinitis 
Pair 2: Subjects with 2 but <4 weeks rhinitis versus subjects without rhinitis 
Pair 3: Prolonged/recurrent rhinitis (4 weeks total duration across follow-up) 
subjects versus subjects without rhinitis 
Factors significantly different in the univariate analysis are highlighted in bold in 
Table 3.1. In comparison to subjects without rhinitis, subjects with 2 weeks rhinitis 
(pair 1) had higher rates of eczema, wheezing (p<0.001), and sensitization to any of 
the tested food (egg, milk, or peanut) (p<0.001), but not against dust mite allergens. 
Other significant factors associated with rhinitis were: parental history of atopic 
diseases, Malay ethnicity (compared to Chinese), usage of antibiotics, and childcare 
attendance (p<0.05) (Figure 3.3).  
Comparison of prolonged/recurrent rhinitis subjects with healthy subjects (pair 3) 
showed similar results. However, rhinitis which lasted only 2-4 weeks (pair 2) was 
not associated with wheeze, parental histories, antibiotics usage in the first 6 months, 
or childcare attendance. These data suggests that prolonged/recurrent rhinitis (4 
weeks) is more closely associated with atopic co-morbidities and parental history of 
atopy. However, as mentioned in the methods (section 2.2.9), the associations 
observed in univariate analysis may be due to potential confounder and covariates, 









Figure 3.3. Univariate comparison of risk and associated factors between 
infants with rhinitis and controls. Each line depicts the odds ratio 
and 95% confidence intervals. A) Rhinitis 2weeks vs controls. B) 







3.3.2. Multivariate Analysis 
Factors significant in any of the 3 univariate analysis models were included into the 
multivariate model (Table 3.2, Figure 3.4) for adjustment for potential confounders 
and covariates. As antibiotic usage in the first 12 months of life was significant in all 
3 univariate pairings, but not antibiotics within the first 6 months, the former was 
included in the multivariate model. 
For 2-4 weeks rhinitis, only food allergen sensitization and antibiotic usage remained 
significantly associated (p<0.05). For prolonged/recurrent rhinitis, more factors 
remained significantly associated. These included food allergen sensitization and 
antibiotic usage, as well as male gender, eczema, wheeze, and maternal and paternal 
histories of atopic diseases. This further substantiates the result of the univariate 
analysis that prolonged/recurrent rhinitis is more closely associated with atopic co-
morbidities and parental atopic histories.  
To further substantiate this finding, a binomial multivariate comparison was 
conducted between subjects with prolonged/recurrent rhinitis against subjects without 
prolonged/recurrent rhinitis (combined 2 - 4 weeks rhinitis and no rhinitis subjects).  
Similar result was obtained, though food sensitization lost its significance (p=0.063). 
Thus, the prolonged/ recurrent definition may be useful to select for rhinitis 









Figure 3.4. Multivariate comparison of risk and associated factors between infants 
with rhinitis and controls. Each line depicts the adjusted odds ratio 
and 95% confidence intervals. A) Rhinitis 2weeks vs controls. B) 







3.3.3. Sensitivity Analysis 
In consideration of the huge proportion of subjects with missing data (352 of 1085 
[32.4%] active subjects), a sensitivity analysis was conducted. The binomial 
multivariate analysis [subjects with prolonged/recurrent rhinitis (4 weeks total 
duration) vs without prolonged/recurrent rhinitis (combined 2-4 weeks rhinitis and no 
rhinitis subjects)] was reanalyzed with subjects who had missing data but at least 
once schedule visit (n=338) reclassified to the latter group (imputed to negative). The 
analysis was conducted once more with the missing rhinitis data subjects considered 
as prolonged/recurrent rhinitis positive (4 weeks total duration) case subjects instead 
(imputed to positive). 
Similar results were obtained with both analyses (Table 3.3). The only differences 
observed were that food sensitization became significant (p=0.045) in the negative 
imputation analysis while paternal history lost its significance, though still 
maintaining a trend (p=0.063) in the positive imputation. As both imputations reflect 
the extreme possibilities for the rhinitis outcome of subjects with missing data, this 







Table 3.3. Sensitivity Analysis: Binomial multivariate analysis with imputed 
data .± 
 
P/R rhinitis missing 
imputed to negative† 
Adj OR (95% CI) 
P/R rhinitis missing 
imputed to positive‡ 







2.11 (1.20 – 3.71)§ 
 
1.00 






4.06 (2.05 – 8.03)§ 
 
1.00 






2.94 (1.02 – 8.46) ¶ 
 
1.00 







2.09 (1.24 – 3.54)§
 
1.00 







1.13 (0.63 – 2.03) 
1.10 (0.50 – 2.43)
 
1.00 
1.42 (0.82 – 2.47) 
1.24 (0.59 – 2.62)





2.22 (1.30 – 3.80)§
 
1.00 






1.89 (1.09 – 3.27) ¶
 
1.00 






0.99 (0.57 – 1.71) 
 
1.00 
0.80 (0.47 – 1.37) 
Post-natal environmental factors 











1.26 (0.54 – 2.93) 











1.78 (1.09 – 2.92) ¶ 
±Each factors were adjusted with each other. Comparison group were subjects 
with no or 2-4weeks rhinitis 
†Subjects with missing data classified as prolonged/recurrent rhinitis negative 
‡Subjects with missing data classified as prolonged/recurrent rhinitis positive 
§p<0.01 compared to healthy group 
¶
 p<0.05 compared to healthy group 
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3.3.4. Factors Associated with Prolonged/Recurrent Rhinitis with Allergen 
Sensitization. 
As reviewed in chapter 1, the PARIS cohort (39) has previously shown that in the 
first 18 months of life, atopic rhinitis (symptoms accompanied with allergen 
sensitization) and non-atopic rhinitis may have differing associated factors. Their 
result suggests that these subsets of rhinitis may be separate entities. While 
prolonged/recurrent rhinitis observed in this study was non-atopic in the majority, 
further analysis of this atopic subset was carried out. Therefore, risk factor analysis 
was conducted to investigate the factors associated with the allergen sensitized subset 
of prolonged/recurrent rhinitis in this study.  
Prolonged/recurrent rhinitis with allergen sensitization (food and/or inhalant) were 
more likely to have eczema (13/20, 65%) compared to those without allergen 
sensitization (26/83, 31.3%) (p=0.005) (Table 3.4). This association with eczema was 
also observed in those with sensitization to any food allergens (p=0.019) and any 
HDM allergens (p=0.005).  
Multivariate analysis was conducted to include possible confounding factors. Factors 
associated with dust, food, or any allergen sensitization with a p value of <0.1 were 
included: ethnicity, antibiotics usage during labour, breastfeeding and dog keeping. 
Breastfeeding up to 12 months was chosen to adjust for breastfeeding of the longest 
duration. Dog keeping at 6 months was chosen over 12 months due to the number of 
missing dog keeping data at 12 months. Co-morbid eczema remained significantly 
associated with any allergen (adjusted p=0.013), food (adjusted p=0.019) and HDM 
sensitization (p=0.013) within prolonged/recurrent rhinitis subjects after the 
adjustments. This result demonstrates that the allergen sensitized subset of the 
prolonged/recurrent rhinitis was more closely associated with the presence of atopic 





3.4. Rhinitis Severity and Disturbances to Daily Activities 
The severity score of rhinitis symptoms within prolonged/recurrent rhinitis subjects 
across each scheduled visit intervals are presented in Figure 3.5. The total symptom 
score increased by 0.52 (
timepoints. Whilst the increase was slight, this statistically significant difference 
indicates that there is an increase of symptom severity with age. 
Figure 3.6 depicts the highest disturbances
among prolonged/recurrent rhinitis subjects within the first 18 months of life. 
Majority of the subjects suffered from some degree of sleeping (71.7%) and feeding 
disturbances (58.0%) attributed to their symptoms. 
their sleeping and feeding activities were reported in 16.7% and 8.7% of 
prolonged/recurrent rhinitis subjects, respectively. 
 
Figure 3.5. Distribution of total sym
occurring at each scheduled timepoints
rhinitis subjects
median denoted by the horizontal line in the middle.
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95% CI: 0.35 - 0.68, p<0.001) at each progressive quarterly 
 
 scores for sleeping and feeding activity 
In addition, severe disturbances to 
 
ptom score (max: 12) for rhinitis episodes 
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3.5 Exploring the Role of Respiratory Viruses  
3.5.1 Scheduled Swabs: Comparing Prolonged/Recurrent Rhinitis Subjects and 
Controls 
To study the role of respiratory viruses in subjects with prolonged/recurrent rhinitis, 
anterior nasal swabs from subjects sampled at the 7 scheduled visits as well as 
additional clinic visits within a month of rhinitis episodes of at least 2 weeks were 
evaluated.  
Analysis of the scheduled visit swabs was conducted on a sub-cohort of 32 
prolonged/recurrent rhinitis subjects (case samples; n=205 swabs) and their matched 
controls (n=215). Figure 3.7 presents the proportion of samples at each timepoint 
with positive detection to any of the 16 targeted respiratory viruses: human rhinovirus 
(HRV), human respiratory syncytial virus (RSV) A and B, human Influenza Virus 
(Flu) A and B, human metapneumovirus (HMPV), human adenovirus (AdV), human 


















None Mild Moderate Severe
Sleep Feed
Figure 3.6. Severity scores for sleep and feeding disturbances in GUSTO subjects 
with prolonged/recurrent rhinitis in the first 18 months. For subjects 
with more than one rating, the most severe rating was used. 
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OC43, HKU1, 229E, and NL63. The detection rate peaked at 15 months within the 
case samples and at 18 months within the contr
detection rate at 18 months for the rhinitis subjects was observed.  There was no 
obvious reason for this and it is possibly a result of random chance.
 
The detection rate of each respiratory virus within the 
samples are presented in Figure 3.8. HRV was the most frequently detected virus
accounting for more than 70% of the detected viruses. HRV was detected in 29/205 
(14.1%) case samples and 27/215 control samples, which corresponds t
case subjects and 16 of 32 control subjects. HRV subtyping was conducted on the 
positive HRV samples, and was successful in all but 3 samples. Of the detected HRV 
subtypes, HRV subtype A was the most commonly detected (67.9%). Minor 
detections of other respiratory viruses (except bocavirus, parainfluenza virus 1, and 2) 
were also observed albeit rarely (max 4 of 420 analyzed samples). 
Generalized estimating equations was utilized to compare the respiratory viruses 













3 weeks 3 months
Figure 3.7. Proportion of 
targeted respiratory viruses
represents the number of swabs analyzed at each timepoint (max 32) 
within the respective subject group.
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measurements into account. There was no significant difference between the virus 
detection rates in the case (19.5%) and control groups (18.1%) (p=0.08). On the other 
hand, samples collected in the presence of symptoms suggestive of upper respiratory 
infection (runny/blocked nose; not necessarily of 2 weeks duration) had higher rate 
(p<0.001) of respiratory virus detection (45.7%) compared to swabs collected without 
the symptoms (10.7%). This difference was still observed when case (p<0.001) and 
control samples (p<0.001) were analyzed separately. 
3.5.2. Additional Visit Nasal Swabs 
Additional visits were arranged near (within a month) of rhinitis episodes identified 
through monthly phone calling. Nasal swabs were collected during these visits to 
describe the respiratory virus detection pattern in the proximity of rhinitis episodes of 
2weeks.  
The result of respiratory virus analysis of additional visits swabs are presented in 
Figure 3.9, along with the result from scheduled swabs (combined case and control) 
for comparison. A similar pattern of respiratory virus detection was observed in the 
additional visit swabs, i.e. HRV was the major type of virus detected (positive in 
17/101 samples from 16 of 87 subjects), with minor detection of other respiratory 
viruses. HRV-A was also the most commonly detected subtype; only 1 of each HRV-
B and HRV-C was detected. 
Overall virus detection rate was higher in the additional visits swabs (28.7%) 
compared to the scheduled visits swabs (18.8%). Logistic regression analysis was 
conducted to compare the respiratory virus detection rate between the 2 sets of 
samples, adjusting for the age of nasal swabbing. The higher rate of detection was 




Figure 3.8. Respiratory virus detection from scheduled quarterly visit swabs: 205 prolonged/recurrent rhinitis (case) samples
samples. No positive viral detection of Bocavirus and Parainfluenza V
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Figure 3.9. Respiratory virus detection from additional visit swabs (101 samples
and control, n=420). No positive viral detection of Bocavirus and Parainfluenza Virus 1, and 2. *HRV subtype cannot be determ
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3.5.3. Seasonality of Respiratory Virus Detection 
Despite being a tropical country with no obvious climatic seasons, a previous study 
conducted in Singapore (156) reported RSV and Human Influenza Virus to exhibit 
some seasonal patterns. Thus the seasonality of respiratory virus detection within the 
analyzed swabs was also investigated to assess the effect of month of swabbing into 
the detection rate. 
The detection rate of any respiratory viruses from samples collected at each month 
was plotted on a scatter-plot. To investigate whether a seasonality pattern of virus 
detection was present, a LOESS curve was fitted to provide a smoothened curve 
along the scatter-plot. As shown in figure 3.10, no distinct seasonal pattern was 




Scheduled visits Additional visits 
Figure 3.10. Fitted trend graph of respiratory virus detection across months of 
sample collection in scheduled (left) and additional (right) visits 
samples. No distinct seasonal pattern was observable. 
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3.6. Summary of Results 
Result from this rhinitis sub-study of the GUSTO birth cohort has shown that rhinitis 
(defined as sneezing, runny/blocked nose of 2weeks) in the first 18 months of life is 
common among Singaporean children (32.1%). This study has identified a subset of 
prolonged/recurrent rhinitis (4 weeks) rhinitis associated with atopic co-morbidities 
as well as parental histories. In addition, the presence of sensitization further 
strengthened the association with co-morbid eczema. This prolonged/recurrent 
rhinitis was also shown to impact the quality of life of the subjects with the disorder. 
Further follow up will determine if this subgroup with prolonged/recurrent rhinitis 
will develop allergic rhinitis in later childhood. 
Molecular analysis of the nasal swabs collected during scheduled quarterly visits did 
not show any increased respiratory virus detection in prolonged/recurrent rhinitis 
subjects compared to controls. However, regardless whether it is from cases or 
controls, higher rates of respiratory virus detection was observed in subjects who 
were symptomatic with runny/blocked nose symptoms (not necessarily 2 weeks) at 
the time of sample collection. More significantly, higher respiratory virus detection 
rates were observed in prolonged/recurrent rhinitis subjects within a month of 
2weeks rhinitis episodes compared to scheduled visit swabs. Taken together, while 
respiratory viruses tended to be detected during acute symptomatic episodes in all 
subjects, the detection of viruses in subjects with prolonged/recurrent symptoms 





Chapter 4: Discussion  
4.1. Epidemiology of Rhinitis 
4.1.1. Prevalence Rates 
Based on studies from other cohort populations (Chapter 1, Table 1.2, Page 12), the 
prevalence of rhinitis in the first 2 years of life ranged widely from 0.8% to 49%. 
This wide range in prevalence may be in part due to differences in each study’s 
definition of rhinitis. In the GUSTO birth cohort study, the prevalence of rhinitis in 
the first 18 months of life was relatively high at 32.1%. Due to the large proportion of 
subjects with missing data (at one or more time point and no positive response in 
other timepoints, 32.4%), the prevalence of rhinitis within the current cohort may be 
overestimated. Nevertheless, the minimum possible prevalence of rhinitis in this 
cohort (assuming every subject with missing data as healthy) was still relatively high 
at 21.7% (235/1085).  
The GUSTO cohort study used a novel definition for rhinitis based on duration of 
symptoms of 2 or more weeks. This contrasts with the more commonly used 
definition developed for the ISAAC study which defined rhinitis as symptoms outside 
cold/flu. The ISAAC study was designed for 6-7 and 13-14 years old schoolchildren 
and virtually, their definition for rhinitis has never been validated in infant and 
preschool ages. In addition, it may be challenging for parents to exclude symptoms 
which is caused by cold/flu, especially in infants and young children (2). Rhinitis 
duration of 2 weeks in the GUSTO study’s definition is based on the ARIA guideline 
recommendation that symptoms of at least 2 weeks should be investigated for causes 
other than infections (1). Furthermore, another study by Mitra et al. reported that 
upper respiratory infections in preschool children rarely lasted beyond 2 weeks in 
duration (142), thus supporting the use of the 2 weeks cut-off as definition for rhinitis 
outside cold/flu.  
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A duration cut-off for early childhood rhinitis was also previously utilized by the 
BAMSE and CAPS birth cohort. The BAMSE birth cohort defined rhinitis as 
symptoms lasting 2 months in the past 12 months and reported a prevalence of 3.5% 
and 3.8% in the first and second years of life respectively (72, 137). This relatively 
low prevalence rate is most likely attributed to the longer duration cut-off in their 
definition of rhinitis. On the other hand, the CAPS (Childhood Asthma Prevention 
Study) (139) utilized a duration cut-off of 1 week and reported current (in past 12 
months) rhinitis prevalence of 42% at the 5th year of life.  
4.1.2. Association with Atopic Co-morbidities and History 
In order to define a subset of rhinitis with onset in the first 18 months of life, that is 
better associated with atopic risk factors and co-morbidities, the data on rhinitis was 
explored. A subset of rhinitis defined by a total duration of 4 weeks across the 
follow-up period in single or multiple episodes of at least 2 weeks was evaluated and 
termed as prolonged/recurrent rhinitis. As shown in Table 3.2 (Page 53), 
prolonged/recurrent rhinitis was significantly associated with eczema, wheezing, and 
parental history of atopic diseases. In contrast, rhinitis of shorter duration (between 
2–4 weeks) did not show these associations. These factors (eczema, wheeze, and 
parental history of atopic symptoms) have been previously reported to be associated 
with early childhood rhinitis as reviewed in Chapter 1.5 (Page 19). Therefore, 
prolonged/recurrent rhinitis may be a useful working definition for rhinitis in the first 
18 months of life which is associated with atopic predisposition and co-morbidities. It 
is currently uncertain if prolonged/recurrent rhinitis is an early manifestation of 
longer term allergic rhinitis that persists into childhood. 
House dust mite (HDM) sensitization is the major aeroallergen sensitization in 
Singaporean children (157). Andiappan et al. recently reported that HDM 
sensitization occurred in the majority (71.3%) of their Singaporean subjects and that 
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sensitization to other aeroallergens were rare in HDM sIgE negative subjects (only 
5%) (158). However, the result from this study shows that HDM sensitization was not 
common among prolonged/recurrent rhinitis subjects (15.9%) and was not associated 
with prolonged/recurrent rhinitis. These data indicate that the majority of early onset 
prolonged/recurrent rhinitis is non-atopic. This observation is in line with the 
proposal by the European population-based multi-cohort study MeDALL 
(Mechanisms of the Development of ALLergy study) that the coexistence of the 
atopic triad: eczema, wheeze, and rhinitis may occur despite the absence of IgE 
sensitization (159). This suggests that IgE sensitization may not be the sole reason for 
the co-existence of these disorders in early life.  
However, the low rate of HDM sensitization within prolonged/recurrent rhinitis 
subjects does not necessarily imply that prolonged/recurrent rhinitis is not a precursor 
of subsequent allergic rhinitis. Since skin prick tests detects systemic IgE 
sensitization, the presence of localized IgE in the nasal mucosa not detectable by SPT 
(160) might be another reason for the low rate of HDM sensitization in this study. 
Veskitkul et al (13) reported that young children with non-atopic rhinitis may develop 
aero-allergen sensitization on subsequent follow up, suggesting that the clinical 
phenotype may precede IgE sensitization to aeroallergens. Further follow-up to track 
the disease progression of prolonged/recurrent rhinitis subjects in this study will 
therefore be necessary to determine if prolonged/recurrent rhinitis is a precursor of 
allergic rhinitis in childhood. 
In contrast to HDM sensitization, food sensitization was found to be associated with 
both rhinitis of shorter duration (2–4 weeks) and prolonged/recurrent rhinitis in this 
study. However, it is unlikely that rhinitis in this study is a manifestation of clinical 
food allergy. Rather, food sensitization may be a feature of atopy and a precursor of 
subsequent aeroallergen sensitization (161). To substantiate this, the German MAS 
cohort (162) reported that hen egg sensitization at 12 months to be a risk factor for 
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aeroallergen sensitization at 3 years. The French ORCA (Observatory of Respiratory 
risks linked with Cutaneous Atopy) cohort (163) have also recently reported 
sensitization to food allergens at 6.5 months of age to be an independent risk factor 
for development of aeroallergen sensitization at 6 year of age. Likewise, preliminary 
analysis of 36 months data of the GUSTO cohort (data not included in this thesis 
which is limited to 18months follow up) have shown that food sensitization  at 18 
months was a significant risk factor of developing new HDM sensitization at 36 
months (OR=8.18 [3.79 – 17.66], p<0.001). This observation further supports the 
observation that food sensitization is an early marker for future HDM sensitization.  
Early allergen sensitization may also contribute to future rhinitis development. The 
MAS (164) cohort reported that food sensitization at both the first and second year of 
life were risk factors for allergic rhinitis at age five. Additionally, subjects with 
sensitization to any food or aeroallergens at 18 months had higher risk for 
development of new rhinitis at age 5 in the CAPS cohort (47). The Taiwanese 
PATCH (Prediction of Allergies in Taiwanese Children) (165) cohorts also reported 
that dust and food sensitization at 18th months was a risk for rhinitis at the age of 
four. Further follow-up of the GUSTO cohort will provide data on the prognosis of 
Singaporean subjects with early allergen sensitization.  
The PARIS birth cohort also investigated rhinitis (using ISAAC questionnaire) within 
the first 18 months of life in a not at-risk population (43). In contrast to this study, 
they reported that rhinitis was associated with neither eczema (red/itchy skin rash 
coming and going for 6 months) nor wheeze (whistling in the chest regardless of 
concurrent infection). It is probable that the definition of rhinitis using duration cut-
off in the current study is more sensitive than the ISAAC questionnaire to detect early 
onset rhinitis associated with atopic co-morbidities (eczema and wheeze). In addition, 
their study also reported association with house dust mite (Der p1) allergen 
sensitization, but not with food allergens. This may stem from the difference in early 
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sensitization profile between the Asian and the European children in both studies. 
Their study reported food and Der p sensitization in 15.0% and only 1.2% of their 
subjects respectively in contrast to this study’s 4.9% and 9.1% respectively. 
4.1.3. Association with Other Demographical and Environmental Factors 
Aside from atopic co-morbidities and parental histories, antibiotic usage within the 
first 12 months of life and male gender were also found to be associated with 
prolonged/recurrent rhinitis. However, the association with antibiotic usage may be 
due to reverse causation, i.e. prolonged/recurrent rhinitis subjects were prescribed 
with antibiotics for their rhinitis symptoms. In addition, as antibiotics usage in this 
study does not specifically pertain to antibiotics used for rhinitis, and may also be 
prescribed to treat co-morbid symptoms or other diseases closely related with rhinitis. 
Regardless, the significantly higher usage of antibiotics among prolonged/recurrent 
rhinitis subjects indicates an increased healthcare utilization cost for these subjects. 
The association with male gender was also observed across several studies (29, 39, 
166), albeit some studies reported no association (23, 41). The male gender is also 
associated with early onset wheeze and this has been attributed to smaller calibre 
airways of males in infancy (167). The PARIS cohort (39) also observed a male 
predominance for allergic (eosinophilia or elevated IgE against food or inhalant 
allergens) but not for non-allergic rhinitis. In addition, the Isle of Wight cohort (131) 
tracked the progression of atopic and non-atopic rhinitis until age of 18, and 
described allergic rhinitis to be male predominated while non-allergic rhinitis to be 
female predominated. Again, further follow-up will be required to observe if male 
gender association also suggests prolonged/recurrent rhinitis to be a precursor for the 




4.1.4. Early Onset Prolonged/Recurrent Rhinitis with Concomitant Allergen 
Sensitization 
When subjects with prolonged/recurrent rhinitis were sub-grouped by allergen 
sensitization, it was observed that the sensitized (to food, house dust mites, or to any 
of the tested allergens) group had a higher likelihood to have concomitant eczema. 
This shows that the atopic subset of prolonged/recurrent rhinitis had a stronger 
association with atopic co-morbidity compared to the non-sensitized group, and 
therefore represents ‘true’ infant onset allergic rhinitis. This early onset atopic rhinitis 
may also be an early indicator for allergic rhinitis persisting into later childhood. 
Regardless, the long term outcome of the non-sensitized subjects will also require 
further follow-up to determine if allergen sensitization and persistence of rhinitis 
symptoms would develop in at least a proportion.  
Interestingly, breastfeeding till 12 months of age was more common in 
prolonged/recurrent rhinitis subjects with accompanying sensitization to food or to 
any allergens. While this may mean that prolonged breastfeeding results in 
sensitization, it may however be related to reverse causation (parents' with sensitized 
children extended their breastfeeding duration).  
4.1.5. The Impact of Prolonged/Recurrent Rhinitis 
To study the effects of prolonged/recurrent rhinitis on the quality of life, its impact on 
feeding and sleeping activities were investigated. This study has shown that more 
than half of prolonged/recurrent rhinitis subjects had had disturbances to these 
activities, and severe sleeping and feeding disturbances were reported in 16.7% and 
8.7% of the prolonged/recurrent rhinitis subjects respectively. This result 
demonstrates that rhinitis is a significant syndrome even within the first 18 months, 
and thus complements a previously published large American survey (168) on the 
burden of allergic rhinitis in preschool and school-aged children, which reported its 
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adverse effects on physical, social, and emotional aspects of life. Similar to the results 
of this thesis, the survey also reported allergic rhinitis to cause sleep disturbances. 
4.2. Exploring the Role of Respiratory Virus 
Several cohort studies such as the COAST (80, 81), COPSAC (81, 84), Perth (82, 
83), and the WHISTLER (85) cohorts have reported respiratory virus detection to 
contribute into the development of preschool wheeze and asthma (also discussed in 
Chapter 1.6.3.1, Page 26). There are only few studies investigating the role of 
respiratory viruses in the development of infancy and preschool age rhinitis. While 
Garcia-garcia et al. (89) did not find any association between metapneumovirus or 
RSV with preschool rhinitis, the CAPPS Canadian Asthma Primary Prevention Study 
cohort reported significant association between parainfluenza virus and enterovirus 
detection with rhinitis in infancy. However, the CAPPS cohort also reported a 95% 
prevalence of rhinitis in first year, which may be due to accidental inclusion of 
infectious rhinitis. Since prolonged/recurrent rhinitis (4 weeks total duration) was 
found to be associated with atopic co-morbidities and history, this study also aimed to 
elucidate the potential relationship between respiratory viruses and prolonged/ 
recurrent rhinitis.  
The overall respiratory virus detection rate was 18.8% of the 420 scheduled visit 
swabs and 28.7% of the 101 additional visit swabs (overall 20.7%). Similarly, the 
American COAST cohort (92) and the Perth cohort (82, 83) also conducted 
respiratory virus samplings at both scheduled and additional timing (during acute 
respiratory episodes) within the first year of life. The COAST cohort reported a 
detection rate of 73% in their additional samples (with severe respiratory symptoms), 
while the rate in scheduled visits with severe, mild, or no respiratory symptoms were 
74%, 64%, and 10% respectively. The Perth cohort detected respiratory virus in 73% 
of acute symptoms samples and in 21.2% of scheduled visits (all collected in the 
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absence of respiratory symptoms). The rates of respiratory virus detection observed in 
this study are lower than that reported in both studies, but similar to the COAST 
cohort’s healthy swabs. This study was not designed to perform nasal swabs at acute 
onset of symptoms or during wheezing episodes.   
The COAST and Perth cohort studies utilized nasopharyngeal aspiration for sampling 
while this study utilized nasal swabbing in consideration for the very young age of 
the subjects during sampling (3 weeks - 18 months). Regardless, anterior nasal 
swabbing has been previously reported to produce comparable specificity and 
sensitivity (144). Scheduled swabs collected in the presence of nasal symptoms of 
runny/blocked nose were found to have significantly higher rate of virus detection of 
more than four-fold in this study. However most of the scheduled swabs were not 
collected during symptomatic episodes (77.6%). In addition, the additional swabs 
were not collected at the onset, but only after the symptoms had been ongoing for at 
least 2 weeks as per this study’s definition of rhinitis. These reasons are likely to 
contribute to the relatively low virus detection rate found in this study which stands 
between the healthy samples of the COAST (10%) and the Perth (21.2%) cohorts. 
HRV was the most frequently detected virus in this study, similar to that observed in 
the COAST (80), WHISTLER (85), and the Perth cohorts (83).  This was also 
reported by our collaborator, Dr Tan Boon Huan in her earlier study. HRV was 
detected in 12.8% of 500 children presenting with acute respiratory infection (169, 
170), similar to the rate of 13.3% in the scheduled swab of this thesis.  However, their 
study reported higher rates of RSV detection (11.8%) compared to this thesis (only 1 
in 420 scheduled samples and 3 in 101 additional samples). The much higher 
detection rated reported by Tan BH et al. is very likely due to the inclusion of 
subjects hospitalized for lower respiratory tract infections, for which RSV infection is 
an established cause (171).  
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Human Rhinovirus consists of over 100 serotypes which are classified into 3 
subtypes: A, B, and C. The advent of molecular methods for respiratory virus 
detection led to the discovery of novel HRV strain which hitherto was undetectable 
by classic culture detection technique. Some strains showed sufficient diversity and 
was thus classified as a new subgroup C (172). HRV subtype C has been found to be 
responsible for more severe respiratory symptoms necessitating hospital admissions 
(173, 174). HRV subtyping was conducted in this study. It was observed that the 
majority of HRV belonged to subtype A (67.9% of HRV positive scheduled samples 
and 15 of 17 HRV positive additional visit samples). The newest subgroup C was 
detected at a lower rate: in 11 (20.8%) of HRV positive scheduled samples and 1 
(5.9%) of HRV positive additional visit samples. There was, however, no statistically 
significant difference in the subtype distribution between the case and the control 
subjects. Dr Tan BH et al. also reported HRV-A (73%) as the major detected HRV 
subtype in Singapore children hospitalized with acute respiratory infection (170). In 
their study, HRV-C was detected only in 2/ 64 (3%) HRV positive samples, which 
was much lower than the rate observed among the scheduled swabs in this thesis, but 
similar to the rate observed in the additional visits swabs in this thesis. 
Analysis of 420 nasal swabs collected at scheduled visits did not reveal any 
significant difference in the virus detection rate between the prolonged/recurrent 
rhinitis subjects and their matched healthy controls. Due to the small difference of 
positive detection rate between both groups (19.5% vs 18.1%), it is unlikely that a 
statistically significant difference would be observed even if the entire cohort was 
analyzed. As such, further analysis of the remaining possible 64 case-control pairs 
was not conducted.  
The additional clinic visits were conducted within a month of rhinitis episodes lasting 
at least 2 weeks in 87 prolonged/recurrent rhinitis subjects. Nasal swabs of 
prolonged/recurrent rhinitis subjects collected during these visits were observed to 
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have higher rates of respiratory virus detection (28.7%) compared to swabs from the 
scheduled visits (18.8%) (adjusted p=0.041). This observation implies that while the 
prolonged/recurrent rhinitis subjects did not shed/carry respiratory viruses more often 
than the healthy controls during symptom free periods, there appeared to be an 
extended period of respiratory virus shedding within a month of a symptomatic 
episode. It has been shown that respiratory virus shedding to remain detectable 
beyond 2 weeks from the onset of symptom onset in 25% children between 2 to 9 
years of age (175). However this prolonged shedding was reported to be unlikely 
observed in infants (176). This observation of extended virus shedding may reflect 
the inability to effectively clear off viruses following rhinitis episodes in 
prolonged/recurrent rhinitis subjects, or their susceptibility to new infections 
following each episode. Additionally, this finding may also suggest that respiratory 
viruses play a role in the symptomatology of prolonged/recurrent rhinitis disorder in 
the first 18 months of life. 
4.3. Conclusion of Thesis 
This study has showed that rhinitis in the first 18 months of life is a common disorder 
with 32.1% prevalence rate. It also identified a subset of rhinitis (prolonged/recurrent) 
in the first 18 months which was defined as total symptom duration of 4weeks with 
each rhinitis episode lasting at least 2 weeks. Of significance is that this subset of 
rhinitis was associated with atopic co-morbidities (eczema and wheeze) and parental 
history of atopic diseases. The atopic march model describes allergic rhinitis as a late 
manifestation (5, 8). In line with this model, the majority of prolonged/recurrent 
rhinitis observed in this study was non-atopic. Despite the absence of allergen 
sensitization, the finding of this study suggests that the prolonged/recurrent definition 
of rhinitis may be used to define early onset rhinitis associated with atopic co-
morbidities, which may in turn be a precursor for future allergic rhinitis. As such, 
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epidemiological studies rhinitis in this age group should also include the duration of 
symptoms as a criterion.  
This study also found that the allergen sensitized subset of prolonged/recurrent 
rhinitis was more closely related to eczema, and may thus represent true infant onset 
allergic rhinitis. Prolonged/recurrent rhinitis was also found to result in disturbances 
to feeding and sleep and is therefore a clinically significant early childhood disorder.  
Prolonged/recurrent rhinitis subjects were not more prone to active virus shedding 
compared to their matched healthy controls when scheduled nasal swabs were 
compared. However, a higher rate of respiratory virus detection was observed in the 
proximity (within a month) of rhinitis episodes 2weeks in subjects with 
prolonged/recurrent rhinitis compared to schedule swabs. This suggests that 
respiratory viruses may play a role in the development of prolonged/recurrent rhinitis 
symptomatology.  
4.3.1 Strength and Weakness 
The GUSTO cohort is the largest prospective birth cohort conducted in Singapore to 
date. The main strength of the cohort is the frequent subject follow-up from 
pregnancy and post-delivery (7 timepoints till 18th months). This allows for a 
comprehensive investigation and study of rhinitis symptoms in the first 18 months.  
Despite the association with atopic history and co-morbidities, it can be argued that 
the prolonged/recurrent definition has not been properly validated. However, the aim 
of this study was to study the phenotypes of rhinitis in the first 18 months, rather than  
to develop a validated questionnaire definition for rhinitis in this age group. In 
addition, due to the difficulty in diagnosing rhinitis (atopic and non-atopic non-
infectious) in this age group, it may prove challenging to validate the 
prolonged/recurrent definition of rhinitis. Replications by future studies may be 
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required instead to confirm the associations between prolonged/recurrent rhinitis with 
atopic co-morbidities and histories. 
Due to ethical consideration, parents of subjects may have opted out of swabbing 
during a scheduled visit even after consenting to the procedure. In addition, visits are 
scheduled within a window period at the convenience of the parents and subjects. As 
such, it is possible that parents whose children were experiencing severe upper 
respiratory symptoms tended to opt out of nasal swabbing during these visits. This 
may in turn led to a skewed representation of the virus studies. Regardless, the effect 
of this skewing is unlikely to be biased towards either  prolonged/recurrent rhinitis 
(case) or control subjects. 
4.3.2 Message to Clinicians 
There has been a lack of clinical guidelines for rhinitis in very young age. The ARIA 
guideline has previously suggested that rhinitis symptoms which lasted for 2 or more 
weeks should be investigated for causes aside upper respiratory infection. The result 
of the current study supports the usage of symptom duration to identify rhinitis 
symptoms which are associated with atopic history and co-morbidities. Therefore, 
despite the lack of allergen sensitization, a subset of non-atopic rhinitis may have a 
more complex underlying cause than just mere acute respiratory infection. As such, 
assessment of the history of symptom duration may assist in the identification of 
these clinically significant rhinitis symptoms.  
Rhinitis with onset early in life has been an unmet medical need, as there has not been 
adequate guideline and recommendations for management of early childhood rhinitis. 
This study has highlighted the need for clinicians to further look into this subset of 




4.3.3 Message to Scientists 
Albeit it is a common knowledge that respiratory viruses are causes for upper 
respiratory symptoms, this study has shown that respiratory viruses may play a role in 
the inception of a more persistent rhinitis phenotype.  Possible molecular mechanisms 
on respiratory viruses induced allergy and asthma had been previously suggested. 
Investigation on the possible mechanism leading to respiratory virus induced early 
childhood rhinitis is therefore warranted. 
4.4 Future Studies 
The GUSTO birth cohort follow-up is currently ongoing with yearly scheduled visits. 
Data from the subsequent visits would provide important information on the outcome 
of prolonged/recurrent rhinitis. It would enable phenotyping of early childhood 
rhinitis, and to examine the prognosis of this clinical entity in association with 
respiratory virus detection in the first 18 months of life. 
An extension of the GUSTO cohort, the Singapore PREconception Study of long-
Term maternal and child Outcomes (S-PRESTO), is being initiated. This cohort will 
recruit Singaporean women planning on (before) pregnancy to explore the role of pre-
conception period factors towards various future clinical outcomes, including the 
development of atopic diseases. Further, previous studies have reported that cord-
blood neutralizing antibodies were associated with an increased risk of wheezing in 
infancy (177, 178). It would thus be of interest to investigate whether antenatal 
respiratory virus infections in mothers would also predispose to prolonged/recurrent 
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 1: Chinese  2: Malay  3: Indian    4 : Others 
 
Baby’s maternal grandfather (mother’s father) 
 1: Chinese  2: Malay  3: Indian    4: Others 
 
Baby’s maternal grandmother (mother’s mother) 
 1: Chinese  2: Malay  3: Indian    4: Others 
 
Baby’s father 
 1: Chinese  2: Malay  3: Indian    4: Others 
 
Baby’s paternal grandfather (father’s father)  
 1: Chinese  2: Malay  3: Indian    4: Others 
 
Baby’s paternal grandmother (father’s mother) 
 1: Chinese  2: Malay  3: Indian    4: Others 
 








Recruitment Visit- 1st Clinic Visit Questionnaire 
What type of accommodation do you live in? 
  
1: 1-2 room HDB flat 
  
2: 3 room HDB flat 
  
3: 4-5 room HDB flat 
  




6: Landed property 
  
7: Others, specify:_________________________________ 
What is the monthly income of your household (before tax deduction)?   
  
1: $0 - $1000 
  
2: $1000 - $2000 
  
3: $2000 - $4000 
  
4: $4000 - $6000 
  





Week 26-28 clinic visit questionnaire 
SMOKING – DURING THIS PREGNANCY 
12.1 Are you currently smoking?  
  
0: No            go to question 12.3     
  
1: Yes 
12.2 If yes, how many sticks per day? Record maximum stated.  
    
12.3 During your pregnancy, did anyone living in your home smoke at home on a  
daily basis?   
  
0: No                 
  
1: Yes 
12.4 During your pregnancy, have you ever had a job in which, on a daily basis, you 
were exposed to cigarette smoke from others?   
  
0: No                go to section 13 
  
1: Yes 
a. On average, how many hours were you exposed to cigarette smoke at work? 
  
1: 1 hour or less 
  
2: 1-3 hours 
  
3: 4+ hours 
b. Are you currently exposed to cigarette smoke at work on a daily basis? 
  









I. INFANT DATA 
3. Gender 1. Male 2. Female 
  
4. Birth Order   
 
5. Gestational age at delivery    
 
IV. DETAILS OF LABOUR AND DELIVERY 
9. Antibiotics during labour: 0. No 1. Yes 
  
9.1 If “Yes”, please specify: 1. Ampicillin 
 2. Augmentin 
 3. Erythromycin 
 4. Others, specify____________ 
 
13. Mode of delivery  1. Normal Vaginal Delivery 
 
 2. Emergency LSCS 
 
 3. Elective LSCS 
 
 4. Assisted breech 
 
 5. Vacuum 
 





3 WEEKS INFANCY QUESTIONNAIRE 
4.1 Did you breastfeed your baby? 





5.1 At any time, has your child had running nose, blocked or congested nose, snoring 
or noisy breathing during sleep or when awake that has lasted for 2 or more weeks 
duration 
 0: No 





3 MONTHS INFANCY QUESTIONNAIRE 
 The following questions refer to the period between the last three months, or 
from the last home visit to the current visit 
1.1. At any time, has your child had running nose, blocked or congested 
nose, snoring or noisy breathing during sleep or when awake that has lasted 
for 2 or more weeks duration 
 0: No 
  1: Yes 
   
1.8. Has your child ever been diagnosed with eczema? 
  *Eczema – a medical condition where skin is red, dry, scaly, itchy and sore 
 0:No 
  1:Yes, specify age of diagnosis   months 
  99: Don’t know    
      
1.9. Has your child ever wheezed? 
  *Wheeze – Noisy breathing with a high-pitch, whistling sound heard from 
chest, not the mouth 
 0:No    
  1:Yes, specify no. of wheezing episodes   months 
  99: Don’t know    
      
1.9.1 If yes, how old was your child at the start of the first episode of wheeze 




   
1.11 Has your child ever been prescribed with nebulizer/inhaler treatment? 
 0: No    
  1: Yes, specify _________    
  99: Don’t know    
      
1.20 Has your child ever had antibiotics?  
  0: No 
  1: Yes (please fill in table below) 
  99: Don’t know 
 
 
S/N   Age (month) 
prescribed  
 Duration taken 
(days)  
 Name of antibiotics  
Indicate 99 if unknown  
 Indications 
 1       
2 
    
3 







2.1 Please indicate your baby’s type of feed in the last 3 months.  












Week 4      
2nd Month     
3rd Month     
 
      
2.2 Are you currently still breastfeeding? 










1.1. At any time, has your child had running nose, blocked or congested nose, 
snoring or noisy breathing during sleep or when awake that has lasted for 2 or more 
weeks duration 
 0: No 
 1: Yes 
  
1.8. Has your child ever been diagnosed with eczema? 
  *Eczema – a medical condition where skin is red, dry, scaly, itchy and sore 
 0:No 
 1:Yes, specify age of diagnosis   months  
 99: Don’t know    
     
1.10. Has your child ever wheezed? 
  *Wheeze – Noisy breathing with a high-pitch, whistling sound heard from 
chest, not the mouth 
 0:No    
 1:Yes, specify no. of wheezing episodes   months  
 99: Don’t know    
     
1.10.1 If yes, how old was your child at the start of the first episode of wheeze 
  Month  Week  
     
1.12 Has your child ever been prescribed with nebulizer/inhaler treatment? 
 0: No    
 1: Yes, specify _________    
 99: Don’t know    
     
1.24 Has your child ever had antibiotics?  
  0: No 
  1: Yes (please fill in table below) 
  99: Don’t know 
 
S/N  Age (month) 
prescribed  
 Duration taken 
(days)  
 Name of antibiotics  
Indicate 99 if unknown  
 Indications  
 1       
2 
    
3 











2.1 Please indicate your baby’s type of feed in the last 3 months.  











3rd month      
4th month     
5th month     
6th month     
 
     
2.2 Are you currently still breastfeeding? 









MONTH 9 INFANCY QUESTIONNAIRE 
1.1. At any time, has your child had running nose, blocked or congested 
nose, snoring or noisy breathing during sleep or when awake that has lasted 
for 2 or more weeks duration 
  0: No 
  1: Yes 
   
1.2. Has your child ever wheezed since the last visit? 
  *Wheeze – Noisy breathing with a high-pitch, whistling sound heard from 
chest, not the mouth 
 0:No    
  1:Yes, specify no. of wheezing episodes   months 
  99: Don’t know    
      
1.2.1 If yes, how old was your child at the start of the first episode of wheeze 




   
1.4. Has your child ever been prescribed with nebulizer/inhaler treatment since the 
last visit? 
 0: No    
  1: Yes, specify _________    
  99: Don’t know    
      
1.15 Has your child ever had antibiotics since the last visit?  
  0: No 
  1: Yes (please fill in table below) 
  99: Don’t know 
 
 
S/N  Age (month) 
prescribed  
 Duration taken 
(days)  
 Name of antibiotics  
Indicate 99 if unknown  
 Indications  
 1     
2 
    
3 
    
 
 
2.1 Please indicate your baby’s type of feed in the last 3 months.  
(INDICATE ‘0’ FOR ALL OPTIONS IF TAKING FRESH MILK OF ANY 
VARIETY) 











7th month     
8th month     
9th month     
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2.2 Are you currently still breastfeeding? 




   
2.16 At what age was your child first fed food other than breast milk or formula milk, 
on a DAILY BASIS? 





MONTH 12 INFANCY QUESTIONNAIRE 
1.8. Has your child ever been diagnosed with eczema? 
  *Eczema – a medical condition where skin is red, dry, scaly, itchy and 
sore 
  0:No 
  1:Yes, specify age of diagnosis   months 
  99: Don’t know    
      
1.10. Has your child ever wheezed in the last 3 months? 
  *Wheeze – Noisy breathing with a high-pitch, whistling sound heard from 
chest, not the mouth 
  0:No    
  1:Yes, specify no. of wheezing episodes   months 
  99: Don’t know    
      
1.10.1 If yes, how old was your child at the start of the first episode of wheeze 
  Month  Week  
      
1.12 Has your child ever been prescribed with nebulizer/inhaler treatment in the last 
3 months? 
  0: No    
  1: Yes, specify _________    
  99: Don’t know    
      
1.16  Has your children had running nose, blocked or congested nose, snoring or 
noisy breathing during sleep or when awake that has lasted for 2 or more weeks 
duration 
 
  0: No    
  1: Yes    
      
1.24 Has your child ever had antibiotics in the last 3 months?  
  0: No 
  1: Yes (please fill in table below) 
  99: Don’t know 
 

S/N  Age (month) 
prescribed  
 Duration taken 
(days)  
 Name of antibiotics  
Indicate 99 if unknown  
 Indications  
 1       
2 
    
3 







2.1 Please indicate your baby’s type of feed in the last 3 months.  
(INDICATE ‘0’ FOR ALL OPTIONS IF TAKING FRESH MILK OF ANY 
VARIETY) 











10th month     
11th month     
12th month     
 
      
2.2 Are you currently still breastfeeding? 









MONTH 15 INFANCY QUESTIONNAIRE 
1.8. Has your child ever been diagnosed with eczema? 
  *Eczema – a medical condition where skin is red, dry, scaly, itchy and sore 
  0:No 
  1:Yes, specify age of diagnosis   months 
  99: Don’t know    
      
1.10. Has your child ever wheezed in the last 3 months? 
  *Wheeze – Noisy breathing with a high-pitch, whistling sound heard from 
chest, not the mouth 
  0:No    
  1:Yes, specify no. of wheezing episodes   months 
  99: Don’t know    
      
1.10.1 If yes, how old was your child at the start of the first episode of wheeze 
  Month  Week  
      
1.12 Has your child ever been prescribed with nebulizer/inhaler treatment in the last 
3 months? 
  0: No    
  1: Yes, specify _________    
  99: Don’t know    
      
1.16  Has your children had running nose, blocked or congested nose, snoring or noisy  
breathing during sleep or when awake that has lasted for 2 or more weeks duration  
in the last 3 months? 
  0: No    
  1: Yes    
      
2.1 Please indicate your baby’s type of feed in the last 3 months.  
(INDICATE ‘0’ FOR ALL OPTIONS IF TAKING FRESH MILK OF ANY VARIETY) 












13th month      
14th month     
15th month     
 
      
2.2 Are you currently still breastfeeding? 
  0: No    





MONTH 18 INFANCY QUESTIONNAIRE 
1.1 Please indicate your baby’s type of feed in the last 3 months.  
(INDICATE ‘0’ FOR ALL OPTIONS IF TAKING FRESH MILK OF ANY VARIETY) 











16th month      
17th month     
18th month     
 
      
1.2 Are you currently still breastfeeding? 




   
3.7 Has your child ever been diagnosed with eczema? 
  *Eczema – a medical condition where skin is red, dry, scaly, itchy and sore 
  0:No 
  1:Yes, specify age of diagnosis   months 
  
99: Don’t know 
 
   
3.9 Has your child ever been diagnosed with asthma? 
  0:No 
  1:Yes, specify age of diagnosis   months 
  
99: Don’t know 
 
   
3.10. Has your child ever wheezed in the last 3 months? 
  *Wheeze – Noisy breathing with a high-pitch, whistling sound heard from  
chest,  not the mouth 
  0:No    
  1:Yes, specify no. of wheezing episodes   months 
  
99: Don’t know 
 
   
3.12 Has your child ever been prescribed with nebulizer/inhaler treatment in the last  
3 months? 
  0: No    
  1: Yes, specify _________    
  
99: Don’t know 
 
   
3.12 Has your children had running nose, blocked or congested nose, snoring or  
noisy breathing during sleep or when awake that has lasted for 2 or more weeks  
duration 
  0:No 
  1:Yes, specify age of diagnosis   months 
 
3.15 Has your child ever been diagnosed with allergic rhinitis? 
  0:No 
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  1:Yes, specify age of diagnosis   months 
  
99: Don’t know 
 
   
SKIN PRICK TEST 
4.4 Skin Prick test done 
  0. No 





Positive control   0. Negative 
1. Positive  

4.4.1.1 Erythema    "   mm 




Negative control   0. Negative 
1. Positive  

4.4.2.1 Erythema    x   mm 




4.4.3 Cow's Milk   0. Negative 
1. Positive 
4.4.3.1 Erythema  x   mm 
4.4.3.2 Wheal    x   mm 

4.4.4 Peanut   0. Negative 
1. Positive 
4.4.4.1 Erythema    x   mm 
4.4.4.2 Wheal    x   mm 

4.4.5 Egg (Whole)   0. Negative 
1. Positive  

4.4.5.1 Erythema    x   mm 
4.4.5.2 Wheal    x   mm 

4.4.6 Der F   0. Negative 
1. Positive  

4.4.6.1 Erythema    x   mm 
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
4.4.6.2 Wheal    x   mm 

4.4.7 Der P   0. Negative 
1. Positive 
4.4.7.1 Erythema    "   mm 
4.4.7.2 Wheal    x   mm 

4.4.8 Blomia Tropicalis    0. Negative 
1. Positive  

4.4.8.1 Erythema    #   mm 




_____________   0. Negative 
1. Positive 
4.4.9.1 Erythema    #   mm 




_____________   0. Negative 
1. Positive  

4.4.10.1 Erythema    #   mm 
4.4.10.2 Wheal    #   mm 
  
4.33 Has anyone in your family ever had the following? (May tick more than 1 boxes) 






Allergic Rhinitis  







Dermatitis  Father  Mother 
Sibling,  
specify_________ 







ENVIRONMENT QUESTIONNAIRE (6 & 12 MONTHS) 
1.1. Does your child attend child care/day care? 
 0: No   go to question 1.6 
  1: Yes 
   
1.2. How many days per week does your child attend childcare/day care? 
 
  days 
      
1.3. How many hours per session of childcare/daycare does your child attend? 
    hours 
     
1.4 At what age did your child begin attending childcare/day care? 
 Month    
      
1.5. Is your child currently still attending childcare/daycare? 
  0: No    
  1: Yes    
      
1.6 Do you have a cat at home? 
  0: No   go to question 1.7 
  1: Yes (please fill in table below) 
 1.6.1 If yes, is the cat kept: 
  1. Inside the house 
  2. Outside the house 
  3. Both inside and outside the house 
1.7 How often has he/she visited homes that keep a cat or cats over the last 6 months? 
  0. Never 
  1. Infrequently (once a month of less) 
  2. Fairly frequently (several times a month) 
  3. Frequently (several times a week) 
  4. Every day or almost every day 
1.8 Do you have a dog at home? 
  0: No   go to question 1.9  
  1: Yes (please fill in table below)  
 1.8.1 If yes, is the dog kept:  
  1. Inside the house  
  2. Outside the house  
  3. Both inside and outside the house  
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1.9 How often has he/she visited homes that keep a dog or dogs over the last 6 months? 
  0. Never 
  1. Infrequently (once a month of less)  
  3. Frequently (several times a week)  
  4. Every day or almost every day  
    
1.10. Do you live near any expressway that you hear the traffic 
  0: No  
  1: Yes  
    
1.11. Does the room that your child is staying in have air conditioning? 
  0: No  
  1: Yes  
    
1.12. What kind of floor covering is your child’s bedroom? 
  1: Fitted carpets  
  2: Loose carpets  
  3: Tiles  
  4: Bare floor  
    
1.13. Anyone in the house smokes? 
  0: No       End of questionnaire  
  1: Yes  
1.13.1. Who is this person? (may tick more than 1 box) 
  Father  Mother  Others, specify____________ 
1.13.2. Frequency of smoking exposure 
 
 1: Daily  
 
 2: more than once a week  
 
 3: others, specify:___________  
 





ENVIRONMENT QUESTIONNAIRE (36M) 
1.1. Is your child attending child care/day care/nursery/classes 
(music/art/Sunday school etc.) 
 0: No   go to question 1.5 
  1: Yes 
 1.2 How many days per week does your child attend the above? 
  days 
   
 1.3 How long are these on an average day? 
  





   
 1.4 At what age did your child begin attending the above? 




MONTHLY PHONE CALL QUESTIONNAIRE 
Questions: 
2. Excluding cold and flu, how long has your child’s nose problem been? : 
      2 weeks 
      2-4weeks 
      >4weeks 
2.1 When did the symptom started and ended? _______________________________ 
3. What were the main problems/ symptoms noted? (can have more than 1 problem) 
Sneezing       No       Yes 
 Runny nose       No       Yes 
 Blocked nose       No       Yes 
 Snoring or noisy breathing      No        Yes 
 Others (specify)  _____________________ 
4. Are the nose symptoms accompanied by itchy-watery eyes? 
     No        Yes 
5. What trigger factors provoke or increase the nose problem? 
Fever                               No     Yes    
Dust No    Yes 
Pollution                           No     Yes   
Cigarette smoke                No      Yes 
Air conditioning               No       Yes  
Animals (cat, dog)            No       Yes 
Feeding (for infants)         No     Yes 
 Others (specify): _________________________ 
6. Are there any other associated symptoms/problems? 
Cough                                                    No         Yes 
Wheeze (or diagnosed as asthma)           No         Yes 
Rashes (or diagnosed eczema)          No         Yes  
Vomiting                                              No         Yes 
Sleep disturbance                                 No         Yes 
Middle ear infection                              No         Yes 
7. Has your child seen a doctor for this problem?  
                   No          Yes 
             If yes, which GP clinic? :_________________ 
Treatment administered / Medication prescribed:________________ 
8. Has your child taken medications for this problem?  
                   No          Yes   
If yes to medication, specify:__________________ 
9. Has your child ever had antibiotics? 
     No          Yes   
If yes to antibiotics, specify:__________________ 
10. Has your child had an allergy test before? 
      No         Yes 
If yes, specify:_______________________ 
11. Would you like to see our doctor for your child’s nose problems? 
     No 
     Yes 
     Not now 





TOTAL NASAL SYMPTOM SCORE 
Circle the points that best match your child’s condition:   
1. Please rate how the nasal congestion symptoms have been over the past 2 
weeks: 
None 0 
Mild (symptoms present, but easily tolerated) 1 
Moderate (symptoms are bothersome, but tolerable.) 2 
Severe (symptoms are hard to tolerate – causes marked interference 
with activities of daily living and/or sleep) 
3 
 
2. Please rate the runny nose symptoms have been over the past 2 weeks: 
None 0 
Mild (symptoms present, but easily tolerated) 1 
Moderate (symptoms are bothersome, but tolerable.) 2 
Severe (symptoms are hard to tolerate – causes marked interference 
with activities of daily living and/or sleep) 
3 
 
3. Please rate the nasal itching symptoms have been over the past 2 weeks: 
None 0 
Mild (symptoms present, but easily tolerated) 1 
Moderate (symptoms are bothersome, but tolerable.) 2 
Severe (symptoms are hard to tolerate – causes marked interference 
with activities of daily living and/or sleep) 
3 
 
4. Please rate the sneezing symptoms over the past 2 weeks: 
None 0 
Mild (symptoms present, but easily tolerated) 1 
Moderate (symptoms are bothersome, but tolerable.) 2 
Severe (symptoms are hard to tolerate – causes marked interference 
with activities of daily living and/or sleep) 
3 
 
QUALITY OF LIFE 
5. Rate how difficult it was to sleep due to nasal symptoms over the past 2 
weeks: 
None 0 
Mild (Little difficulty falling asleep. Might wake up once a night every 
few nights) 
1 
Moderate (woke up more than once a night on most nights) 2 
Severe (barely able to sleep. Awake most of the night on most nights) 3 
6. Rate how much the nasal symptoms interfered with feeding over the past 2 
weeks: 
None 0 
Mild (Occasionally interrupted by nasal symptoms but feeds well) 1 
Moderate (Interrupted almost every feeding by nasal symptoms or 
feeding is slightly slowed down) 
2 
Severe (Feeds very slowly most of the time due to interruptions or 
irritability) 
3 
